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CHAPTER I 
INTRODUCTION 
Ever since the first clinical case of Gram-negative 
bacteremia was described by Brill and Libman in 1899 (19). 
septic shock and its research laboratory equivalent, endo-
toxic shock, have become an increasingly important clinical 
as well as experimental problem. Based on 1974 population 
studies. McCabe estimated that there would be 330,000 re-
ported cases of bacteremia with 132,000 deaths within the 
United States per year (144). The mortality rate has re-
mained extremely high, while the incidence of sepsis 
and presumably endotoxemia -- has increased over the years 
since 1974 (85). U~ing currently available statistics (206) 
and McCabe's estimates of incidence and mortality (144), 
there will be 380,000 cases of sepsis and 150,000 deaths 
per year. In his book The Lives ££ ~ ~~ Thomas (202) 
states that the presence of bacterial endotoxin in the blood 
stream is interpreted as "the very worst of bad news." 
2ndotoxin provides a signal to the host of the presence of 
overwhelming numbers of Gram-negative bacteria and the re-
sponse is a fight to the death. Unfortunately the massive, 
"panic-driven" mobilization of the defense only leads to .. ~ne 
host's demise. As Thomas (202) concludes: ~~e are, in 
1 
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effect, at the mercy of our own Pentagons • • • In spite of 
extensive experimental observations, the mechanisms which 
lead to the state of circulatory and metabolic collaps~ 
caused by Gram-negative bacterial endotoxins are net clearly 
understood. 
Recently, the state of ~etabolic failure which leads 
to severe hypoglycemia and which is accompanied by the state 
of circulatory failure has been a major focus. Siegel (192) 
and Duff (42) have proposed that the metabolic changes which 
occur during sepsis may underwrite the ensuing circulatory 
syndrome during clinical septic shock. In light of this 
concept they propose that extensive monitoring of the meta-
belie status along with the already accepted monitoring of 
circulatory status in septic patients be used as a guide to 
treatment and that, indeed, treatment should be aimed at 
correcting the disturbed metabolic state rather than merely 
supporting the cardiovascular system. While the profound, 
progressive hypoglycemia during endotoxin or septic shock 
has been well-documented in a number of species including 
dogs and man, the possible relationship between metabolic 
and cardiovascular failure has not been fully explored. 
The research included in this dissertation examines 
the role of hypoglycemia in the development of cardia-
vascular failure during endotoxin shock in the dog in order 
to answer the following questions: Is hy?oglycemia merely 
a parallel manifestation of the underlying endotoxic 
3 
syndrome, or does hypoglycemia play a causative role in the 
development of circulatory failure following endotoxin ad-
ministration and if so, in what ways does hypoglycemia con-
tribute to the pathogenesis of cardiovascular failure? 
Specifically, the purposes of this dissertation are fourfold: 
1) to develop a canine ~odel for the continuous monitoring 
of blood glucose levels for the induction of well-regulated 
alterations in the glycemic state -- i.e. a glucose clamp, 
and to assess cardiovascular performance; 2) to correlate 
hemodynamic events with changes in blood glucose levels 
following endotoxin administration; 3) to evaluate whether 
hypoglycemia ~ ~ induces changes in cardiovascular per-
formance potentially leading to a state of circulatory shock 
and to compare the cardiovascular alterations of hypoglycemia 
with those of endotoxicosis; and 4) to evaluate the possible 
synergistic effects of hypoglycemia and endtoxin and con-
versely the potential beneficial effects of maintenance of 
blood glucose -- at either normoglycemic or hyperglycemic 
levels -- during shock. 
CHAPTER II 
LITERATURE REVIEW 
Metabolic and Cardiovascular Failure 
during-Circulatory Shock 
Carbohydrate Dyshomeostasis 
during Endotoxin Shock: Alterations 1£ 
Blood Glucose Levels 
Observations on blood glucose levels during shock 
date back to Bernard (1877) who reported hyperglycemia fol-
lowing hemorrhage (214). While such hyperglycemia has been 
confirmed by a number of workers (see references 131, 157, 
184, 214, 215 for a complete list of references with regard 
to studies of blood glucose levels during hemorrhage), it 
is evident that this is an early phenomenon and that hypo-
glycemia is seen following the transition from reversible 
to irreversible hemorrhagic shock (41, 214). The glycemic 
responses are variable: Some animals die in the hypergly-
cemic phase (131) while others show no initial hyperglycemia 
and exhibit a continuous fall in blood glucose from the on-
set of hemorrhage (36). Zarly hyperglycemia followed by 
hypoglycemia has also been described clinically during car-
diogenic shock (174). 
This biphasic pattern -- early hyperglycemia and late 
hypoglycemia -- is also seen during septic and endotoxic 
4 
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shock and has been reported in several species (11, 51, 57, 
) Many of the early observations on blood glucose during as • 
endotoxin shock were made during experiments on rabbits (25, 
122, 150, 151, 203, 223). Menten and Manning (150, 151) 
were the first to demonstrate early hyperglycemia followed 
by hypoglycemia in rabbits using dead bacteria, a crude 
endotoxin preparation. Penner and Klein (171) were the 
first to observe the blood glucose changes in dogs fol-
lowing endotoxin administration, but their results were 
anecdotal and they did not follow blood glucose through the 
late hypoglycemic stage. Berk and coauthors (9) reoorted 
finding two patterns in blood glucose levels in endotoxic 
dogs. One group showed hyperglycemia followed by hypogly-
cemia; the other proceeded immediately into hypoglycemia 
with a continuous fall in blood glucose from the onset of 
the syndrome. The results of Berk et al. (9) are similar 
to those of Cowley et al. (36) using a hemorrhagic model. 
However, neither group of investigators could be certain 
they did not miss a hyperglycemic phase with only periodic 
measurements of blood glucose. Hinshaw and coinvestigators 
also saw the second pattern of marked ~ypoglycemia with no 
early hyperglycemia in non-surviving endotoxic dogs (100). 
Dogs which survived endotoxemia, on the other hand, were 
better able to maintain their blood glucose levels. Wilson 
et al. reported a similar correlation between the ability to 
maintain glucose levels and survival in septic baboons (217). 
Carbohydra~e Dvshomeostasis: Mechanisms Leading to 
Hynoglycem~a during Endotoxin Shock 
-
6 
The mechanism of shock-induced alterations in blood 
glucose is still a matter of debate, especially with regard 
to the development of hypoglycemia during endotoxin shock. 
Two mechanisms have been postulated to contribute to the 
profound hypoglycemia of endotoxin shock: 1) depression of 
hepatic gluconeogenesis -- along with glycogen depletion in 
fed animals -- (12, 53, 54, 57, 88, 147) and 2) increased 
peripheral glucose utilization (5, 53, 56. 57, 88, 152, 173, 
218). Wolfe, Elahi, and Spitzer (218) have shown a failure 
to maintain an elevated level of gluconeogenesis in spite of 
the falling blood glucose level. Thus, while they conclude 
otherwise, gluconeogenesis was relatively depressed in their 
model since it was not elevated during developing hypcgly-
cemia. The importance of increased peripheral glucose util-
ization versus decreased hepatic glucose production, prob-
ably depends on the stage of endotoxin shock: increased 
peripheral utilization making a greater contribution early 
with decreased hepatic glucose production playing an in-
creasing role as the shock syndrome progresses (219). 
Kuttner and Spitzer (124) have shown that gluconeogenesis 
may, in fact, be elevated during early endotoxicosis. 
The question remains how endotoxin causes these 
insulin-like effects. One possible mechanism is a direct 
effect of endotoxin on several tissues (notably adipose 
tissue and skeletal muscle) to increase glucose oxidation 
(107, 110, 180, 197). While in some cases the direct ef-
fect has been difficult to establish (53, 110), it is gen-
erally accepted that endotoxin may have a direct insulin-
like effect under at least some conditions. Since the di-
rect effect has only been established in vitro or in iso-
lated, perfused organ systems it is difficult, however, to 
assess whether these effects occur during the endotoxic 
syndrome in vivo. 
The crux of the debate over the mechanism of endo-
toxin-induced hypoglycemia centers around the possible 
mediation by humoral factors: What substances are involved 
and what are the sources of these mediators? The stage of 
endotoxin shock is also an important consideration in dis-
cussing which mediators are involved since different fac-
tors may be released at different stages to initiate and 
maintain the metabolic events which lead to the progressive 
hypoglycemia. Buchanan and Filkins demonstrated a marked 
hyperinsulinemia in rats following endotoxin administration 
(23). Yelich and Filkins have shown with both perfused 
livers and pancreata (220) that this hyperinsulinemia is 
not due to an alteration in insulin clearance by the liver 
(a finding disputed by Cornell (35)), but to a hypersecre-
tory state of the beta-cells of the endocrine pancreas. 
The levels of serum insulin decrease late in the endotoxic 
rat as the blood glucose level falls (52). This finding 
8 
o£ hyperinsulinemia is still disputed by Adeleye and co-
(1) The role of insulin in the development of workers • 
endotoxin hypoglycemia in the dog, however, is not well 
defined and even more confusing. Blackard and coinvesti-
gators reported increased insulin secretion only when 
endotoxic dogs were given a glucose load (14). However, 
the results which they reported for untreated dogs are 
open to an alternative interpretation. Insulin levels were 
not increased above control in the untreated group; on 
the other hand, the levels do not decrease as would be 
expected in the profoundly hypoglycemic animal until the 
very late stages o£ shock immediately preceding death. 
This implies that there is at least a functional hyperin-
sulinemia since insulin secretion did not decrease normally 
with the drop in blood glucose. If insulin secretion was 
not properly braked in the face of extreme hypoglycemia, 
the pancreas may have been secreting more insulin than it 
should for the given blood glucose level -- thus, exacer-
bating the hypoglycemia. More recently, Spitzer and 
colleagues have described a brief increase in insulin 
release which occurs very early after endotoxin administra-
tion in the dog (199). After this early elevation, plasma 
insulin levels declined steadily for the remainder of the 
course of endotoxin shock in their model. Other groups 
have reported results which conflict with those of Black-
ard et al. even after a glucose load -- demonstrating 
9 
instead a hyuoresnonsive state of the endocrine pancreas 
( 142). Thus, because it is hard to reconcile these facts, 
the possible role of insulin during canine endotoxin· shock 
has never been clearly defined. Yet, the question of 
whether there is a hyperinsulinemia in the endotoxic dog 
is potentially important. 
In addition tc immunoreactive insulin, there may be 
one or more non-suppressible insulin-like substances in-
volved in the pathogenesis of endotoxic hypoglycemia. Even 
in control animals non-suppressible insulin-like activity 
(NSILA) is 90% or more of the total biological insulin-
like activity (222); therefore, it should not be surprising 
that NSILA is a factor in the development of endotoxic 
hypoglycemia. Filkins has recently demonstrated in the 
late stages of endotoxicosis in the rat that the NSILA is 
indeed elevated (52). In addition, Filkins has shown that 
at least a portion of this rise in NSILA may be due to the 
secretion of an insulin-like substance by macrophages (50). 
Besides immunoreactive insulin and non-suppressible 
insulin like activity, other humoral substances may be 
involved in the development of endotoxic hypoglycemia. 
Berry and coworkers have found a substance produced by 
macrophages which antagonizes the gluconeogenic activity 
of glucocorticoids (10, 156). Pardini, Jones, and Filkins 
have shown that catechola~ines are depleted from nerve 
terminals in the myocardium and spleen during endotoxin 
10 
shock in the rat (166). As this may apply to other organs 
such as the pancreas and liver, the catecholamine depletion 
.a, ave several important effects on metabolism: First, may 
the vasoconstriction caused by the excessive neural drive 
which leads to the depletion may cause an increased peri-
pheral utilization of glucose because of the limitation on 
organ perfusion. Second, decreased flow of gluconeogenic 
substrate to the liver because of increased peripheral 
vasoconstriction may also help explain depressed gluconeo-
genesis. Third, if catecholamines are depleted from nerve 
terminals in the liver, such depletion would lead to loss 
of sympathetic support for gluconeogenesis. Fourth, if 
catecholamines are depleted in the endocrine pancreas, one 
of the normal brakes on insulin secretion would be released. 
While the catecholamine depletion has only been studied in 
heart and spleen, this mechanism -- while speculative -- may 
be important in the development of endotoxic hypoglycemia. 
Another important factor which may mediate the 
effect of endotoxin on peripheral glucose utilization is 
tissue hypoxia. It is well-known that hypoxia and ischemia 
increase peripheral glucose utilization and it has been 
' shown that this is a potential mechanism for increasing 
glucose use by skeletal muscle during endotoxin shock (181). 
~owever, Romanosky et al. (186) have shown that this is not 
a ~ecessary condition for increased glucose utilization in 
.J.' • , • v~~3 ~~ssue. 
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Which tissues are utilizing glucose during endotoxin 
shock is another important question. Some tissues such as 
skeletal muscle may be using inordinate amounts of glucose 
at the expense of vital organs such as the brain and the 
heart. During endotoxin shock in the rat, Filkins and 
Figlewicz (56) have shown increased glucose oxidation by 
liver, hemidiaphragm, spleen and epididymal fat pad, but 
not in blood, lung, brain, heart, stomach, and kidney. 
Raymond and Emerson demonstrated depressed cerebral glucose 
utilization in the endotoxic dog (179). Spitzer and his 
colleagues (136, 198) have demonstrated a shift from free 
fatty acids to lactate in the myocardium. Liu, Long, and 
Spitzer (137) more recently have examined myocardial glu-
cose utilization in vitro in response to endotoxin in 
addition to palmitate and lactate. ITsing isolated myocytes 
from normal dogs, they found that glucose oxidation was 
stimulated directly by increasing doses of endotoxin. 
While these in vitro data in large part parallel previous 
in vivo studies, the relationship between a direct in vitro 
effect and the in vivo effect is not clearly established 
since it is still possible that other mechanisms come into 
play in vivo. Kuttner, Apantaku, and Schumer (123) showed 
changes in glycolytic intermediates in endotoxic rat hearts 
which are consistent with increased glycolytic flux, but 
they did not oeasure glucose utilization. These results are 
also consistent with the findings of Marchetti et al. (143) 
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who demonstrated a slight increase in glucose utilization 
in endotoxic dog hearts in vivo. It has been demonstrated 
by several groups of investigators that the major increase 
in glucose utilization is seen in skeletal muscle which is 
more than 50% of the body mass ( 181 , 186). While Hinshaw 
and coinvestigators (89) demonstrated increased glucose 
utilization in leukocytes from endotoxic dogs, it seems 
unlikely that blood cells can make a significant contri-
bution to the increased peripheral glucose metabolism. 
Sayeed and Murthy (189) demonstrated an approximate doubling 
in glucose oxidation of endotoxic lung slices as compared to 
control slices. Overall, the consensus is that the major 
glucose utilizer during endotoxin shock is skeletal muscle 
with perhaps some minor contribution from fat, lungs, blood 
cells, and possibly the ~yocardium, thus depriving the 
brain of its necessary fuel. Although it has not been ex-
tensively studied, liver may also be an important utilizer 
of glucose following endotoxin administration (56). 
Su~ma=v of Carbohydrate 
D , -t · d · "' d -~- · s· , ysnomeos as~s ur1ng ~n OuOXln necK 
In summary, following the administration of endo-
toxin in a number of species -- including the dog -- a 
progressive, profound hypoglyce~ia develops ~hich may or 
may not be p=eceeded by a brief period of hyperglycemia. 
:his hypoglycemia is produced by a depression in heoatic 
gluconeogenesis and increased peripheral utilization of 
glucose especially in skeletal muscle brought about by a 
direct insulin-like action of endotoxin and by the media-
tion of hypoxia and ischemia as well as several humoral 
factors such as insulin, non-suppressible insulin-like 
activity, and glucocorticoid antagonizing factor. 
Circulatory Failure: ~ Endotoxic Syndrome 
Classically shock is defined as a cardiovascular 
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syndrome. This is no less true of endotoxin shock. The 
first systematic studies of the cardiovascular events fol-
lowing endotoxin administration in the dog were those of 
Wail and MacLean and their coworkers in 1956 (140, 209). 
Following the administration of endotoxin three hemody-
namic phases have been described: an initial hypotensive 
episode within minutes after bolus injection, a recovery 
phase, and a subsequent more prolonged hypotensive phase 
culminating in death (30, 67, 157). The initial hypo-
tensive episode is poss~bly caused by the release of 
histamines (98, 103, 207) as well as other mediators such 
as the endorphins (106, 183) and may well be a systemic 
anaphylaxis (140, 196, 209). The release of these media-
tors leads to dilation in the systemic vasculature, an in-
crease in pulmonary resistance, and a decrease in venous 
~eturn resulting in a decreased cardiac output. The init-
al hypotension leads to massive sympathoadrenal discharge. 
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(S 7 ) with peripheral vasoconstriction and an improvement in 
cardiac performance. Sympathetic outflow, thus, results in 
a partial recovery of venous return, cardiac output, and 
mean arterial pressure. There is, however, a second hypo-
tensive phase characterized by a more gradual decline in 
blood pressure leading to irreversible shock and death (87). 
Early studies of this second phase demonstrated decreases 
in both peripheral resistance (61, 87, 95, 104, 209) and 
cardiac output (87, 95, 104, 209). In later studies in-
creases (61, 78, 87) or no change (78, 87) in peripheral 
resistance were observed. The reasons for the discrepancy 
noted in peripheral resistance are not fully clear. Anes-
thesia, species differences, and the conditions of the ex-
periment as well as when and where (i.e. which vascular 
beds) the measurements were made may very well make a dif-
ference in the response seen. Regardless of the response, 
both peripheral vascular and cardiac mechanisms are involved 
in the events which eventually lead to total circulatory 
collapse and death. 
Cardiovascular Failure during 
~ndotoxin Shock: ?erioheral Vascular Mechanisms 
Characteristics of the injuries resulting from endo-
toxin administration in the dog are the hemorrhagic intest-
inal lesions first noted by Weiland MacLean (140, 209). 
:hese lesions result from splanchnic vasoconstriction, 
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increased portal pressure, and hepatosplanchn!c pooling 
and congestion (140, 209). Park, Baum, and Guntheroth 
(167) noted constriction of the portal vein in the dog. 
Active venoconstriction in the splanchnic bed following 
endotoxin administration was also seen in small mesenteric 
and intestinal veins by Meyer and Visscher (153) and Hin-
shaw and Nelson (99). While all of these groups obtained 
similar results on different veins, Park and colleagues 
disputed the concept of splanchnic pooling. The other 
groups felt that vasoconstriction was the mechanism re-
sponsible for the splanchnic pooling. This dispute can be 
reconciled because Park et al. considered pooling in the 
splanchnic circulation as a large vein phenomenon instead 
of considering the splanchnic circulation as a whole. 
Clearly, venoconstriction increases splanchnic venous 
pressures and decreases venous volume. However, venocon-
striction also increases resistance to venous outflow and 
pooling will occur in the splanchnic microcirculation. The 
concept of splanchnic pooling is consistent with the 
finding of an increased splanchnic blood volume by Chien 
et al. (31). This conclusion is also consistent with the 
finding of increased hepatic wedge pressure by Tsargaris, 
Gani, and Lange (205). As a result of splanchnic pooling, 
venous return is decreased leading to a decrease in cardiac 
output and, thus, perpetuating the shock state. Splanchnic 
pooling along with an overall decrease in splanchnic flow 
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leading to severe splanchnic ischemia (77, 135, 165) can 
lead to the production and release of cardio- and vasotoxic 
materials from the ischemic splanchnic viscera (126, 127). 
such toxic materials as the myocardial depressant factor 
(MDF) reported by Lefer and coinvestigators (126, 127) may 
be the primary mechanism leading to irreversible shock and 
death. 
Decreases in renal blood flow have been reported 
following endotoxin administration in the dog in response 
to the systemic hypotension (102). The decrease in renal 
blood flow resulted in a decrease in GFR and urine output 
(102). More recently, using inert gas washout techniques, 
Neiberger ~nd Passmore demonstrated that renal cortical 
flow was reduced to a greater extent than renal ~edullary 
flow i~ the endotoxic dog (160). These investigators also 
demonstrated that alpha-adrenergic vasoconstriction plays 
a major role in decreased renal cortical flow. While ini-
tially the decrease in renal blood flow is compensatory for 
the systemic hypotension, there are two i~portant detri-
mental consequences which result from prolonged renal cor-
tical ischemia: First, prolonged renal cortical ischemia 
and cortical necrosis would ensure that dysfunction is 
irreversible. Even if blood flow can be restored the kid-
neys would still fail. Second, relative ~aintenance of 
wedullary flow would lead to a washout of the nor~al os-
~otic gradient for urine concentration. T~is latter 
1 is particularly important since anuria does not prob em 
always occur following endotoxin administration (102). 
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Continued urine flow without the ability to properly con-
centrate the urine would further exacerbate the shock state. 
Vasoconstriction has also been demonstrated in the 
skeletal muscle vascular bed following endotoxin admini-
stration (181). As mentioned previously this may contri-
bute to the increase in peripheral glucose utilization and 
the end-product of glucose metabolism (e.g. lactate and 
hydrogen ions) in turn contribute to the vasoconstriction 
in this bed. Vasoconstriction is largely a compensatory 
mechanism, however, to help maintain systemic blood pres-
sure and central blood volume. 
Cerebral and coronary blood flow have also been 
measured during endotoxin shock. Myocardial ischemia has 
been demonstrated following the administration of endotoxin 
in the dog (15, 94, 115). Blood flow has been shown to 
be decreased in several different regions of the brain 
following endotoxin administration including several re-
gions involved in cardiovascular and respiratory control 
(21, 168, 191). Altered autonomic control may be an im-
portant mechanism leading to decompensation and irrever-
sible shock and a number of investigators (109, 191, 203) 
have postulated that depression of the central nervous 
system leading to failure of support of cardiac performance, 
peripheral vascular failure, and respiratory depression 
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iS a major contributor to the cardiovascular and respi-
ratorY failure of endotoxicosis. The decrease in blood flow 
to the brain is largely due to the fall in blood pressure 
since Bryan and Emerson found either unchanged or decreased 
resistance in the seven regions which they studied (21). 
Parker and Emerson (168) also demonstrated that cerebral 
autoregulatory responses were maintained. 
Besides the possibility of central nervous system 
involvement during endotoxin shock, Trank and Visscher 
(204) have shown that cardiovascular afferent systems may 
be altered following the ad~inistration of endotoxin in 
dogs. Using the isolated carotid sinus technique, these 
authors demonstrated higher carotid sinus nerve discharge 
frequencies at most pressures following the administration 
of endotoxin. Thus, the baroreceptors were found to be 
reset to a hypotensive level following endotoxin injection. 
This provides an explanation for the bradycardia and the 
variable response of total peripheral resistance during 
canine endotoxin shock. Now the cardiac and peripheral 
vascular responses will depend on the difference between 
the actual blood pressure and the new set point which is 
lower than the control set point. Paradoxically, then 
the baroreceptor reflex could operate to lower the blood 
pressure through decreases in heart rate and contractility 
and decreases in peripheral resistance as the blood pres-
sure rises back toward control levels. Halinen (74) has 
19 
demonstrated that other cardiovascular afferent systems, 
particularly atrial receptors and the aortic arch barore-
ceptors, are also depressed during endotoxin shock. Thus, 
cardiovascular control may be upset following endotoxin ad-
ministration for two reasons: 1) depression of the central 
nervous system and 2) resetting of baroreceptors and atrial 
volume receptors. In addition to these events in the sys-
temic vascular beds, there is a maintained elevation in 
pulmonary vascular resistance throughout the course of en-
dotoxin shock (87). 
Along with the effects of endotoxin on systemic and 
pulmonary resistance and their neural control, endotoxin 
has been shorNn to cause an increase in capillary permea-
bility in a number of vascular beds including the skeletal 
muscle, pulmonary, and splanchnic beds (32, 33, 194). 
Increased vascular permeability leads to a loss of fluid to 
the extravascular space and a consequent decrease in blood 
volume, thus, aggravating the shock syndrome. Zndotoxin 
also triggers both classic and the alternate complement 
activation pathways as well as both the intrinsic and ex-
trinsic coagulation pathNays (158). These reactions lead 
to disseminated intravascular coagulation, increases in 
vascular permeability, and host defense reactions which 
cause tissue injury and decreased tissue perfusion. 
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C rdiovascular Failure during E~dotoxin Shock: ~ ~ 2£ ~ Heart 
-
The role of cardiac failure in the decompensatory 
of circulatory shock is often debated. Classically, phase 
it has been presumed that the function of the heart as 
~ell as the brain is preserved during circulatory shock or 
only secondarily fails late in the course of shock as a 
result of peripheral vascular failure (72, 86, 87, 95, 
209). Early studies during endotoxin shock pointed to 
decreased venous return (101) as the major cause of de-
creased cardiac output during the initial phases of endo-
toxicosis and showed the heart to be resistant to the 
detrimental effects of endotoxin during the early stages. 
(93, 97). The evidence of Solis and Downing (193), based 
on ventricular function curves in endotoxic cats, however, 
pointed to the potential for very early myocardial failure 
(within the first two hours). A large body of evidence in 
the endotoxin literature now points to the importance of 
early direct myocardial injury leading to cardiac failure. 
necently Hess et al. (80) have attempted to systematically 
study the determinants of cardiac Performance in endotoxic 
' -... 
dogs: heart rate, preload, afterload, and myocardial con-
tractility. They found increased afterload (as assessed 
by total peripheral resistance), decreased preload (as 
assessed by pulmonary capillary wedge pressure), and 
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decreased cont~actility (as assessed by stroke work along 
with no change in heart rate in their model). When animals 
were given a femoral artery-to-vein shunt. myocardial per-
formance was improved along with preload and afterload 
(i.e. left ventricular filling pressure was increased 
while total peripheral resistance was decreased). While 
the methods may be somewhat crude. this study serves to 
point out that myocardial performance after endotoxin is 
affected both by changes in the extrinsic factors of pre-
load and afterload -- i.e. peripheral vascular mechanisms 
-- and by an intrinsic depression of the ability of the 
myocardium to contract. \ 
Two aspects of cardiac performance are altered fol-
lowing endotoxin injection: 1) heart rate and rhythm and 
2) contractility. Most studies have emphasized the de-
pression in myocardial contractility, however, the heart 
rate and rhythm disturbances may be as important. Levy 
and Blattberg (133) describe some important effects of 
endotoxin on heart rate depending on anesthesia. In un-
anesthetized dogs they found a triphasic change in heart 
rate: a transient tachycardia, followed by bradycardia and 
then a secondary tachycardia. In dogs anesthetized with 
pentobarbital there was a similar initial tachycardia fol-
lowed by a prolonged bradycardia, while in ~orphine-chlor-
alose-urethane anesthetized dogs there was an initial 
tachycardia over a somewhat longer period than in the other 
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two groups followed by a return of heart rate to control 
levels and then a second accelerati~n in heart rate. They 
discussed the role of reflex activation of the sympathetic 
versus activation of cardiac vagal fibers in determining 
the heart rate under the various anesthetic conditions 
following endotoxin injection. Of particular interest is 
the paradoxical bradycardia seen during endotoxin shock. 
While the mechanism of this bradycardia is incompletely 
understood, it has drastic consequences for the maintenace 
of cardiac output following endotoxin administration. As 
mentioned before, the resetting of various cardiovascular 
receptors may play a role. More recent studies have shown 
that an unidentified serum factor may be involved in al-
tering cardiac electrophysiology during endotoxin or 
septic shock (27, 28). Recently, Pellet et al. (169) have 
demonstrated increased effective refractory periods, in-
creased conduction times (as measured wi~h His bundle re-
cordings) and bradycardia along with increased sino-atrial 
node recovery times after an extrastimulus in endotoxic 
dogs. These results imply depressed automaticity of the 
sinoatrial node and depressed conduction during canine 
endotoxicosis. The authors speculatively discuss the 
possible role of depressed responses to sy~pathetic stim-
ulation and of myocardial depressant factor in producing 
these effects. However, they do not present data oer-
taining to these potential mechanisms. 
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:.fyocardial ischemia has been demonstrated during 
endotoxin shock (15, 94, 115). Thus, one would expect 
that all of the myriad effects of myocardial ischemia ~n 
myocardial performance -- including dysrhythmias and de-
pressed contractility -- occur following endotoxin admin-
istration. While a number of investigators have demon-
strated a coronary flow deficit during endotox~n shock 
there remains, surprisingly, some debate as to the effects 
of this flow deficit on myocardial function. While Bohs 
et al. (15) found a biphasic increase in coronary vas-
cular resistance and a decrease in coronary flow they were 
unable to get an improvement in myocardial function after 
increasing· coronary flo•N" with dipyridamole. Thus, while 
demonstrating the presence of myocardial ischemia during 
endotoxin shock, these investigators provide some evidence 
that myocardial depression may not simply be due to the 
ischemic process. Other factors may be involved. On the 
other hand, dipyridamole has been shown to be ineffective 
during angina pectoris since it merely causes a redistri-
bution of flow rather than improving flow to ischemic 
regions --the so-called coronary steal phenomenon (40). 
The results of Bohs et al. (15) also conflict with those 
of Peyton et al. (172) who found significant improvement 
in myocardial function following treatment with sodium 
nitroprusside which lowers left ventricular afterload thus 
decreasing the left ventricular oxygen demand relative to 
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the supply (40). Hess and various coinvestigators (115, 
118 , 120) have shown dysfunction of sarcoplasmic reticulum 
calcium uptake and myofibri:lar ATPase which is greater in 
the subendocardium than in the subepicardium. This is con-
sistent with a global ischemic process and the greater sub-
endocardial flow deficit which occurs under these conditions. 
These investigators also presented microscopic evidence of 
differential subendocardial injury. Other studies from 
this same laboratory (20, 81, 195) found that maintenance 
of venous return protected against myocardial failure fol-
lowing the administration of endotoxin. Hess and his 
colleagues concluded that the maintenance of venous return 
with a bypass pump or via a femoral artery-to-vein shunt 
resulted in a maintenance of coronary blood flow. Coronary 
blood flow, however, was not measured in these studies and 
other explanations for improved myocardial performance 
during maintained venous return experiments are possible. 
In studies with retrograde perfused canine hearts where 
myocardial blood flow was artificially maintained, Elkins 
et al. (44) also found improved myocardial function. 
Improved function was also associated with increased cora-
nary flow in studies of the effects of glucose and insulin 
on myocardial performance in endotoxic dogs (4, 90). In 
these studies, however, the effect of the treatment could 
not conclusively be attributed to an improvement in blood 
flow. 
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Another major hypothesis for· the deficit in myocar-
dial performance following endotoxin injection is the toxic 
£actor theory principally espoused by Lefer and associates 
(70 , 126, 127). Lefer and colleagues have discovered a 
myocardial depressant factor (MDF) which is produced from 
proteins released into the blood stream from the ischemic 
pancreas during shock and acted upon by lysosomal hydrolases 
from the liver to form MDF (49, 128, 129). This serum fac-
tor has been shown to depress the contraction of isolated 
oaoillary muscle strips (126, 130) and to be transferable 
. . 
to non-shocked animals (185). This theory is consistent 
with the results reported by McCaig and Parratt (145) who 
found depressed inotropic responses. to calcium administra-
tion in vivo but not in vitro. In another study, ~cCaig et 
al. (146) could find no in vitro physiological or ultra-
structural evidence of myocardial depression in isolated 
atria or papillary muscle taken from cats 2.5 hours after 
endotoxin administration. This is again consistent with 
the idea that a serum factor causes the endotoxic myocardial 
dysfunction rather than intrinsic damage to the heart. 
Other investigators have not been able to demonstrate a 
myocardial depressant factor (96). In addition, shock 
still occurs following endotoxin injection in eviscerated 
dogs (173). Thus, while the evidence for a toxic factor is 
fairly strong, the possible role of MDF in the pathogenesis 
of endotoxic cardiac failure has been questioned. 
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In addition to a possible toxic factor other humoral 
agents may be involved in the pathogenesis of myocardial 
failure during endotcxicosis. Recently Reynolds et al·. 
(183) have demonstrated improved myocardial function as 
assessed by maximum left ventricular dP/dt as well as in-
creased survival following treatment of endotoxic dogs with 
naloxone. Thus, negative inotropic effects of endogenous 
opioids may play a role in the development of endotoxic 
cardiac failure. Another potential humoral mediator of 
endotoxic cardiac failure is histamine. Krause and Hess 
(119) demonstrated an improvement in the ability of myo-
fibrillar ATPase to hydrolyze ATP following treatment with 
diphenhydramine, an antihistamine. Another study of the 
same laboratory showed a beneficial effect of diphenhy-
dra~ine on the uptake of calcium by sarcoplasmic reticulum 
in endotoxic myocardium (79). While this evidence for 
histamine involvement is very indirect, and really inccn-
elusive in the absence of data showing that histamine de-
presses myocardial function in either control or endotoxic 
hearts, it nevertheless points to a potential mechanism 
for endotoxic myocardial failure. 
?ulmonary resistance is increased throughout the 
course of endotoxin shock (87). The afterload to right 
ventricular ejection is, thus, increased. ,.,.,. . . ... n.:s .:s a 
classical mechanism leading to right heart failure. ...,. . " .:.'1l.gn 
rigit ventricular afterload, thus, undoubtedly, contributes 
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to endotoxic cardiac failure. 
Another aspect of endotoxic myocardial failure may 
invclve the response to positive inotropic stimuli. Areher 
and coinvestigators (6) found depressed responsiveness to 
infused epinephrine as assessed by maximum negative and 
positive left ventricular dP/dt, and myocardial power and 
efficiency. A depression in the coronary blood flow re-
sponse to catecholamines was also demonstrated in this same 
study, thus, potentially exacerbating the myocardial is-
chemia. A similar depression in the response to norepi-
nenhrine has recently been demonstrated by Lust et al. (138) • 
. 
These decreases in responsiveness are in addition to the 
previously mentioned depletion of myocardial norepinephrine 
late in endotoxin shock demonstrated by Pardini and his 
coinvestigators (166). 
ninshaw (84) has also suggested that disturbances 
in myocardial calcium and potassium may contribute to the 
myocardial failure. Another contribution to the endotoxic 
cardiac failure may be the mitochondrial swelling, dis-
ruption of the contractile ele~ents with intracellular 
edema, and the increase in extracellular fluid in the 
myocardial interstitium which have been reported in the 
endotoxic heart (34, 91, 92, 149). 
diovascular Failure during ~~otoxin Shock: Summary 
-
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Both peripheral vascular collapse and cardiac fail-
have been shown to contribute to endotoxic circulatory ure 
collapse. An overall increase in total peripheral resist-
ance is seen which may or may not be maintained over the 
entire time course of shock. Specific increases in re-
sistance have been reported in the splanchnic circulation 
where pooling and congestion leading to hemorrhagic intest-
inal lesions which are pathognomic of endotoxin shock in 
the dog. Arteriolar constriction in the splanchnic bed 
may lead to the production of cardia- and vasotoxic ma-
terials which are released during an autoregulatory escap~ 
in the splanchnic vasculature. Resistance has also been 
show~ to increase in the kidneys where renal cortical is-
chemia and an imbalance between cortical and medullary 
blood flow have detrimental consequences for survival, and 
in skeletal muscle where ischemia contributes to the in-
crease in peripheral glucose utilization. 3lood flow to 
the brain and heart haYe also been shown to be decreased 
following endotoxin administration. ~ardiovascular re-
flexes are depressed as a result of central nervous system 
depression and by resetting of baroreceptors and atrial 
volume receptors. Several mechanisms contribute to endo-
toxic cardiac failure: Ischemia, myocardial depressant 
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tor endogenous ooioids, histamine, altered sympathetic fa,C ' • 
Ponses, increased afterload to right ventricular ejec-res. 
tion, myocardial edema, and altered myocardial calcium· and 
potassium have all been postulated to contribute to this 
failure. None of these postulated mechanisms is mutually 
exclusive and several or all of them may contribute to the 
myocardial failure seen after endotoxin injection. The 
exact mechanism is still in dispute. 
Early Studies £! ~ RelationshiP 
.£! Hetabolic ~ Circulatory Failure 
Following Endotoxin Administration 
Several groups of investigators have examined the 
effects of glucose infusion during endotoxin or septic 
shock. In 1975, Weisul et al. (211) studied the beneficial 
effects of glucose, insulin, and potassium solutions in 
patients with sepsis and speculated on the potential role 
of hypoglycemia in the myocardial lesions of clinical septic 
shock. Berk et al. (9) found significant improvement in 
the survival of endotoxic dogs following glucose admini-
stration except at the higher doses of endotoxin studied. 
These authors also found differences in blood pressure 
based on whether the dogs went through an early hypergly-
cemic phase. Hinshaw and coworkers (100) demonstrated im-
proved survival in the dog when glucose levels were main-
tained at oreshock levels, and, in addition, found a posi-
tive correlation between the ability of an animal to 
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. tain ~lucose homeostasis and survival -- only three out ma~n . o 
of eleven animals surviving endotoxic administration with-
out glucose treatment. Similar results have been obtained 
by Wilson et al. (217) in the baboon. Hinshaw's studies 
(1oo), however, in contrast to the results of Berk (9), 
demonstrated protection even at the relatively high dose of 
endotoxin used in this study (LD 70 ). Hinshaw et al. (90) 
and Archer et al. (4), however, were unable to demonstrate 
a protective effect of glucose on the endotoxic myocardium, 
but these results were obtained using a donor perfused dog 
heart model in which myocardial failure could not always be 
demonstrated following endotoxin administration (84). 
Spitzer, Wagner, and Blackard (200) also have published 
data which is consistent with a beneficial effect of glucose 
treat~ent -- showing improvement in mean arterial pressure, 
heart rate, and cardiac output in dogs receiving an LD 70 
dose of endotoxin and glucose treatment. These authors 
also found significant hyperinsulinemia following glucose 
infusion in endotoxic dogs. This explains both the lack of 
any increased 24 hr survival in this study since all in-
fusions were stopped after 5 hrs and provides a potential 
explanation for the differences in the results of the Hin-
shaw experiments (100) and the Berk (9) studies -- at the 
higher doses of endotoxin in the Berk studies the animals 
may have become significantly hyperinsulinemic so that fol-
lowing glucose treatments the dogs became hypoglycemic 
leading to the death of the animals. 
The bulk of the data in these studies consists of 
survival data. Thus, it is not clear what the mechani"sm 
for increased survival is. It seems likely that mainte-
nance of blood glucose levels during endotoxin shock will 
be beneficial whether or not glucose dyshomeostasis plays 
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a causative role in the demise of the animal or whether it 
is merely symptomatic of the overall cardiovascular and 
metabolic failure. More importantly, the technology for 
continuous blood glucose monitoring and thus for maintenance 
of controlled alterations in the glycemic state was not 
available until recently. The glucose clamping experiments 
included in this dissertation are based on new techniques 
and are appropriate to provide more definitive evidence for 
the role of hypoglycemia in the pathogenesis of circulatory 
failure following endotoxin administration. While the idea 
that hypoglycemia plays an important role in the development 
of circulatory failure during shock is not new -- Carl 
Wiggers speculated on this point in his classic monograph 
(214) -- and while several studies have lent credence to 
this concept, none are '.vholly conclusi're. Furthermore, the 
site of action of the protective effects of glucose and pre-
sumably the detrimental effects of hypoglycemia has not 
been clearly established. 
CHAPTER III 
EXPERIMENTAL DESIGN AND RATIONALE 
Two sets of experiments were designed to study the 
role of glucose dyshomeostasis in the develpoment of car-
diovascular failure during endotoxin shock. The first ma-
jor set of experiments entailed the measurement of various 
cardiovascular parameters (see section on cardiovascular 
measurements in Chapter IV - Methods) along with glucose, 
insulin, and lactate without any interventions to alter 
blood glucose in order to correlate the changes in blood 
glucose with the depression of cardiovascular function 
during endotoxin shock. The second major set of experi-
ments was an attempt to alter the pattern of the cardiovas-
cular events of endotoxin shock by controlling blood glu-
case -- at hypoglycemic, normoglycemic, and hyperglycemic 
levels -- using a "glucose clamping" technique. If glucose 
dyshomeostasis plays a critical role in the development of 
circulatory failure, then 1) development of metabolic fail-
ure must precede development of circulatory failure (or at 
least the critical events of metabolic failure must precede 
the critical events in the development of cardiovascular 
failure) and 2) altering the pattern of metabolic failure 
by controlling the blood glucose levels should lead to a 
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detectable alteration in the development of cardiovascular 
failure. 
To test the aforementioned hypothesis four types of 
experiments were performed: 1) unclamped, 2) hypoglycemic 
clamped, 3) hyperglycemic clamped, and 4) normoglycemic 
clamped. In each experiment one group of dogs received 
saline after the appropriate control period and the other 
group of dogs received endotoxin. The endotoxin injected 
dogs were followed until their death from endotoxin shock 
up to a maximum of 10 hrs. The saline injected dogs pro-
vided a time-matched series of control dogs which were 
followed for a period equal to cr exceeding the maximum 
time of survival of the corresponding endotoxic dogs. 
Relationshiu £f Hemodynamic ~vents 
to Metabolic Events during Endotoxin 
Shock -- Unclamned Studies 
The first major set of experiments in which no inter-
ventions were made allowed the assessment of the time re-
lationships of the events of metabolic and cardiovascular 
failure during canine endotoxicosis. While all of the in-
dividual measurements made in this set of experiments have 
been made previously by others and published, without con-
tinuous glucose monitoring it has not been possible to make 
this type of correlation. Furthermore, the presence or 
absence of an early hyperglycemic phase and the relation-
ship of such a phase to the development of circulatory 
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could not be conclusively demonstrated ~ithout con-failure 
tinuous blood glucose monitoring. Thus, this first set of 
experiments is imp~rtant for determining the sequence· of 
metabolic and vascular events. 
Cardiovascular Function in the Endotoxic ~ 
during Altered Glycemrc-states 
Glucose Clamoing Studies 
The primary purpose of the glucose clamping experi-
ments was to alter blood glucose concentration in order to 
determine whether such an alteration changes the pattern of 
cardiovascular events in the endotoxic dog. If development 
of glucose dyshomeostasis plays a critical role in the de-
velopment of circulatory shock (even if it is not the only 
factor), then clamping the glucose at different levels --
hypoglycemic, normoglycemic, and hyperglycemic -- should 
cause a change in the pattern of development of circulatory 
shock: glucose deprivation would be detrimental to the 
maintenance of circulatory function, while maintenance of 
glucose supplies would be beneficial. Thus, glucose 
clamping should lead to predictable alterations in cardio-
vascular performance and survival in the endotoxic dog. 
A secondary purpose of glucose clamping was to study 
the insulin responsivity and glucose utilization rates of 
endotoxic dogs. The question of insulin responsivity in 
endotoxicosis is an important and ~uch debated question. 
The technique of glucose clamping -- at hyp~rglycemic and 
Oglycemic levels -- has been used by DeFronzo, Tobin, norm 
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and Andres (38) to measure glucose utilization and insulin 
responsivity in humans. If this technique could be adapted 
to the endotoxic dog in combination with continuous glucose 
monitoring, it would help to answer this important question. 
In the DeFronzo technique (38) the hyperglycemic 
clamp provides an index of the beta-cell response to glucose 
while the normoglycemic clamp provides an index of tissue 
insulin responsivity. The measured parameters in this tech-
nique are blood glucose, serum insulin, and the rates of 
glucose and insulin infusion. In the hyperglycemic clamp, 
the infusion rate of glucose reflects glucose utilized after 
correcting for the error between thd desired clamp level and 
the actual blood glucose level -- i.e. the glucose utilized 
will be greater than or less than the glucose infused de-
pending on whether the actual blood glucose is less than or 
greater than the desired glucose level. This error can be 
corrected for with knowledge of the glucose space and of 
the urinary excretion of glucose during the clamp. The 
hyperglycemic clamp can also be used to determine the tis-
sue responsivity to endogenous insulin levels using the 
ratio of glucose utilized to the peripheral insulin level. 
In the normoglycemic clamp, as developed by DeFronzo 
(38), insulin is infused at a constant rate sufficient to 
raise the serum insulin levels significantly above normal. 
Glucose is then infused at the rate needed to maintain 
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normoglycemia. Again the glucose infused is converted to 
glucose utilized in response to the insulin load. In nor-
moglycemic clamps the glucose utilized reflects the tissue 
responsivity to exogenous insulin. In addition, the meta-
bolic clearance rate of insulin can be determined by di-
viding the insulin infusion rate by the difference between 
the basal insulin concentration and the concentration dur-
ing the infusion. The adaptability of this technique to 
the endotoxic dog is dependent on two factors: First, that 
endogenous glucose production is negligible during glucose 
infusions, and second, that the glucose space does not 
change significantly during endotoxin shock. It is poss-
ible that neither of these factors is negligible in the en-
dotoxic animal, but it is nevertheless worthwhile attempting 
to adapt this technique to the endotoxic dog since it pro-
vides a simple way of studying tissue insulin responsivity, 
beta-cell glucose responsiveness, and peripheral glucose 
utilization in the intact animal. 
CHAPTER IV 
METHODS 
Exnerimental Grouns 
A total of 46 dogs were included in these experi-
ments. Another 28 dogs were excluded from the study be-
cause of difficulties in completing the protocol or in tol-
erating the instrumentation procedures. The 46 dogs inclu-
ded in these studies were divided into 8 groups: 1) un-
clamped saline-treated contra~ dogs (N=5), 2) unclamped 
endotoxin-treated dogs (N=16), 3) saline-treated hypogly-
cemic-clamped dogs (N=5), 4) endotoxin-treated hypogly-
cemic-clamped dogs (N=6), 5) saline-treated hyperglycemic-
clamped dogs (N=3), 6) endotoxin-treated hyperglycemic-
clamped dogs (N=4), 7) saline-treated normoglycemic-clamped 
dogs (N=3), and 8) endotoxin-treated normoglycemic-clamped 
dogs (N=4). Specific protocols are discussed in the fol-
lor,ving section. 
Endotoxin Prenaration 
Escherichia coli endotoxin (055:35), prepared by Dif-
co (Detroit, MI) using the Boivin method, was used in this 
study. The same batch of endotoxin (controi number 6555468) 
was utilized in all experiments to provide for consistent 
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potency throughout the study. The endotoxin was suspended 
in o.9% saline to a concentration of 5 mg endotoxin/ml. 
Every dog received the same weight-adjusted volume of endo-
toxin or vehicle. The endotoxin dose of 8 mg/kg was chosen 
to provide a very high lethality (100%) over a 10 hr period 
in untreated dogs. Using this dose of endotoxin (in a total 
of 53 dogs given endotoxin and undergoing at least part of 
one of the four protocols) one dog succumbed during the in-
itial hypotensive phase and one additional dog died during 
the early hyperglycemic phase. Also two dogs died during 
the glucose clamping phase of the hypoglycemic clamp exper-
iment and one during the clamping phase of the hyperglycemic 
clamp experiment. Thus, while 8 mg/kg is a high dose of 
endotoxin, most dogs went through the usual pattern of 
events -- the only real effect of this high dose being to 
shorten the time course so that the blood sampling needed 
for the various measurements could be made without compro-
mising the ability of the animals to survive. 
Canine Model 
Mongrel dogs of either sex weighing 18.9±0.5 kg 
(X±S.E.M., range 14.5-26 kg, N=46) were used in this study. 
All dogs were kept in the animal facilities for at least one 
week prior to their experimental use. Dogs were fed (Pu-
rina Dog Chow) midmorning every day through the day prior 
to the acute experiment. Dogs were also free of any 
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sio~ns of infection such as mucous discharge from the 
obvious 
diarrhea prior to the acute experiment. When nee-nose or 
essary, dogs were given a course of penicillin or other 
appropriate antibiotics to treat an existing infection and 
observed to be outwardly symptom-free prior to their exper-
imental use. Thus, although the previous infectious his-
tory was highly variable and largely unknown, all dogs were 
in apparent good health at the time of experimentation. 
All dogs were routinely given a prophylactic course of 
tetracycline antibiotics and were treated for intestinal 
parasites. In addition all dogs were vaccinated against 
rabies, canine distemper, and parvo virus. 
Initial Surgical Procedures 
Food was withheld from all dogs for the 24 hrs prior 
to the acute experiment (i.e~ they were last fed on the 
morning of the previous day). During this period of time 
all dogs continued to receive water ad libitum. Dogs were 
anesthetized intravenously via the cephalic vein of the 
forelimb with sodium pentobarbital (NEMBUTAL, 30 mg/kg). 
This dose was supplemented with J-4 mg/kg every 1-1.5 hrs 
during the experiment to maintain a level of anesthesia 
(see (69) for dosage schedule). In order to minimize the 
cardiovascular depressant effects of pentobarbital 
especially in endotoxic dogs -- these supplemental doses 
were diluted to 10 ml with saline so that they could be 
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slowly over a 3-5 min period. In spite of this pre-given 
caution. twelve endotoxic dogs died during anesthetic sup-
plementation partway through a protocol. Data from those 
dogs which died during anesthetic supplementation were ex-
cluded from analysis. 
Following initial anesthetization a tracheotomy was 
performed. All dogs were then intubated with a glass or 
plastic Y-tube and allowed to breathe on room air sponta-
neously. Both femoral veins were cannulated to allow for 
intravenous infusions and for simultaneous venous sampling. 
The right femoral artery was cannulated for withdrawal of 
arterial samples for the measurement of arterial blood gases 
and pH. Arterial P02, PC02, pH and bicarbonate were mea-
sured in blood samples obtained every 15 min during control 
periods and every 30 min during experimental periods using 
a Corning 165/2 semi-automatic blood gas and pH analyzer. 
The blood gas analyzer was calibrated daily with standard 
buffers of pH 6.838 and 7.382 and with calibration gases 
containing 12% 02, 5% C02• balance nitrogen and O% 02 , 10% 
C02, balance nitrogen. The ambient barometric pressure was 
checked daily and the percentage compositions were con?erted 
to partial pressures assuming a body temperature of J7°C 
and saturation with water vapor (vapor pressure at 37°C, 
47 mmHg). The calibration gases are bubbled through sep-
arate humidifier bottles to saturate the gases prior to 
entering the sample chamber. The calibration for both oH 
41 
and blood gases (oxygen and carbon dioxide) was checked 
periodically throughout the experiment and remained rela-
tively stable (pH: ±0.005 units and oxygen and carbon diox-
ide: ±2 mmHg). If the calibration drifted outside these 
specified ranges the instrument was recalibrated. Rectal 
temperature was monitored in all dogs with a YSI thermistor 
probe. As body temperature can significantly affect meta-
bolic variables, this temperature was maintained between 36 
and 39°C with a heating pad and by covering the animal uith 
surgical drapes during the experiment. 
Cardiovascular Instrumentation 
Electrocardiogram 
All recordings were made on a Grass model 7 eig~t 
channel polygraph. A lead II electrocardiogram was rou-
tinely recorded using needle electrodes in the skin of both 
hindlimbs and the right forelimb. This lead was chosen to 
provide reasonably large upright QRS complexes. Heart rate 
was counted using fast traces of the electrocardiogram 
taken every fifteen minutes. 
Left Ventricular Performance 
and Svstemic Arterial Pressure 
A Millar catheter-tip transducer (model PC 470) was 
introduced via the left femoral artery and positioned in 
the left ventricle for the measurement of left ventricular 
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pressure. The pressure wave form was used as the sole 
guide in proper placement of this transducer. Occasionally 
a ventricular dysrhythmia was induced during the placement 
o£ the Millar catheter. Such dysrhythmias could usually be 
suppressed by manipulating the catheter within the ventricle 
or in some cases by treating with lidocaine as necessary 
( 1-2 mg/kg i v). In any case no animal was used for exper-
imentation in which the presence of a dysrhythmia or the 
treatment necessary to suppress it compromised ventricular 
performance as assessed by left ventricular pressure, dP/dt, 
cardiac output, and systemic blood pressure. Two dogs died 
of ventricular fibrillation after placement of this catheter 
and three additional dogs could not be used due to the pre-
sence of ventricular tachycardia which persisted in spite 
of treatment even after the catheter was removed from the 
ventricle. 
This transducer provides a good frequency response 
(0 to 20 KHz) and avoids the problems of fluid-filled cath-
eter systems. There is less than 1 mmHg/hr drift; thus, 
over the course of a 10 hr experiment there is less than 
10 mmHg drift. The catheter could be placed during an 
acute experiment without opening the chest and without 
requiring prior chronic implantation as with some other 
intravascular transducers. 
The signal from this transducer was electronically 
differentiated and recorded on an adjacent cnannel, The 
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differential could then be used as a marker of end-diastole 
on fast traces so that end-diasto~ic pressure could be mea-
sured. In some cases a Millar catheter with a second· trans-
ducer placed 4 em behind the tip (Model PC 770) was used 
allowing the simultaneous recording of systemic blood 
pressure from the root of the aorta. This method of mea-
surement of systemic blood pressure was useful since a 
check on valve performance was provided. However, this 
particular catheter could not be used in every case since 
blind place~ent using only the pressure as a guide is more 
difficult due to the smaller diameter of the distal cath-
eter segment and the greater flexibility of the material 
that this segment is made of. In most cases the single 
transducer catheter was used and systemic blood pressure 
was measured from the catheter in the right femoral artery 
using a Statham P23ID transducer. 
Left ventricular stroke work was calculated from 
the peak left ventricular pressure, the cardiac output 
(see the following section), and the heart rate using the 
following formula: 
Left Ventricular Stroke Work= LVP x (C.O./HR) (1) 
where, LVP = peak systolic pressure 
c.o. = cardiac output 
HR = heart rate 
3ecause of the frequency response characteristic of the 
Grass model 7 recorder dP/dt cannot accurately be measured. 
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In the present study dP/dt was used only for timing of 
cardiac events because of this limitation of the recorder. 
Thus, stroke work was used instead to quantify cardiac-
performance. Both dP/dt and stroke work, however, suffer 
from the problem of being sensitive to preload, afterload, 
and heart rate as well as myocardial contractility. Thus, 
with either index it is difficult to separate peripheral 
vascular and cardiac events. Both indices have been used 
to assess cardiac performance during endotoxin shock. 
However, caution must be used in concluding that a cardiac 
mechanism is involved. 
The Measurement of Cardiac Cutout 
and ~ Pulmonary Artery Pressure 
A number seven French Swan-Ganz balloon catheter 
(110 em in length) for the measurement of mean pulmonary 
artery pressure and cardiac output was introduced into the 
right external jugular vein and guided through. the right 
side of the heart and into the pulmonary artery using the 
pressure wave form. The catheter was inserted until it was 
~edged with the balloon fully inflated; after which the 
balloon was deflated and the catheter was secured in place. 
Visual inspection on post-mortem examination has demon-
strated that the tip was then in one of the major branches 
of the pulmonary artery. Numerous studies by Edwards 
Laboratories have shewn that the trans-cardiac loop of 
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catheter can either shorten or lengthen depending on changes 
in cardiac performance and warming of the body of the cath-
eter to blood temperature -- thus. either wedging the·tip 
of the catheter or allowing it to fall back into the right 
ventricle. Thus, it was necessary to periodically readjust 
the position of the catheter when mean pulmonary pressure 
could no longer be measured at the tip (either because it 
was wedged or because the tip had moved back into the right 
ventricle as determined by the pressure record). In some 
dogs a few ventricular premature beats were seen during the 
passage of the catheter through the right heart. Inflation 
of the balloon whenever the catheter was in the right ven-
tricle minimized dysrhythmias since floating the catheter 
tip tended to keep the catheter away from the ventricular 
wall. The soft material with which this catheter is made 
and the brief excursion through the right side of the heart 
also tended to minimize the occurrence of dysrhythmias. 
Cardiac output was measured every fifteen minutes 
throughout the experiment using the thermodilution technique 
(see (132) for a good recent review of the thermodilution 
technique). Cardiac output was converted to cardiac index 
by dividing cardiac output by the surface area of the dog 
which was calculated on the basis of weight with the formula 
appropriate for the weight range of dogs used in this ex-
2j3 
periment: S.A. = 0.114 x W · (13, 75: note that the con-
atant 0.114 is the average of the two values given in the 
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references). The appropriate mean arterial pressure is 
divided by the cardiac index to determine the systemic and 
Y vascular resistance (the venous pressure for. pulmonar 
both beds is assumed to be 0 for this calculation). The 
average of 3-5 serial measurements of cardiac output made 
at the end of each fifteen minute period is reported. With 
each measurement 3 ml of ice-cold 0.9% saline were injected 
as rapidly as possible into the proximal port (nominal vol-
ume 0.92 ml) of the Swan-Ganz catheter. This port is lo-
cated 30 em behind the tip of the catheter and when the 
catheter is properly placed it lies in the superior vena 
cava proximal to the right atrium. This positioning allows 
for adequate mixing before reaching the pulmonary artery. 
Care was always taken to inject during the same part of the 
respiratory cycle (end-inspiration) this is especially 
important in the dog because of the large azygous vein 
drainage in this species which is intermittent during the 
respiratory cycle. Care was also taken to minimize syringe 
handling prior to injection in order to avoid significant 
warming of the injectate. The temperature change is de-
tected by a thermistor embedded in the catheter 4 em behind 
the distal port at the tip. This thermistor is connected 
to an Sdwards model 9520A cardiac output computer which 
performs the necessary calculations to obtain cardiac out-
put in liters per minute. A second thermistor used to mon-
itor the temperature of the injectate bath is also connected 
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•he cardiac output computer. Both bath temperature and to ~ 
blood temperature can also be displayed by the cardiac out-
put computer. 
The thermodilution technique is essentially an indi-
cator-dilution technique in which temperature rather than 
concentration is used to determine the distribution of the 
indicator. The temperature detected by the thermistor in 
the pulmonary artery is dependent on the properties of heat 
exchange between the ice-cold saline injectate and the blood 
and surrounding tissues. These properties in turn are de-
pendent on the heat capacity of saline and blood and the 
rate of blood flow past the thermistor. Since the heat 
capacities are a constant and known quantity, the tempera-
ture will vary according to the rate of flow past this 
thermistor ~- i.e. at high rates of flow heat exchange is 
more rapid and the temperature change will be smaller while 
at low flow rates the "cold" injectate is carried away less 
rapidly and the temperature change is consequently larger 
and more prolonged. The mathematical derivation of this 
property is the following equation: 
flow = 
(2) 
where, Pr 
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= density of injectate 
= heat capacity of in-jectate 
= seconds/minute 
= correction for temp-
erature change prior 
to injection 
= injected volume (cor-
rected for residual 
volume of catheter 
= blood temperature 
= injectate temperature 
= density of blood 
= heat capacity of blood 
integral of thermodilution 
curve 
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The terms which do not include temperature are all constant 
and are combined to form a calibration constant which is 
dialed into the cardiac output computer prior to use. For 
3 ml of ice-cold saline the calibration constant calculated 
by ~dwards Laboratories after numerous trials is 0.132 for 
the model 9520A cardiac output computer. This constant is 
reasonably accurate for injectate temperatures in the range 
0-5°C. Blood and injectate temperatures are continuously 
stored prior to injection and the cardiac output computer 
uses the values stored just prior to starting the integra-
tion in the calculation of the cardiac output. The Edwards 
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computer calculates an analog integration of the thermodi-
lution curve which is automatically terminated at the point 
where the curve returns to 30% of its peak. This cuts-off 
approximately 22% of the area which is compensated for math-
ematically in the calculation of cardiac output by electron-
ically multiplying the integral by 1.22. This cutoff point 
was chosen experimentally by Edwards Laboratories as being 
the point of minimum variability in the downslope of the 
curve. Beyond this point there is a release of heat from 
the heart and blood vessel walls which distorts the tail 
end of the curve. This is not, however, true recirculation 
which does not occur in the thermodilution technique. 
Several factors influence the reproducibility and 
accuracy of the measurement of cardiac output by the thermo-
dilution method. First, the volume and temperature of the 
injectate are important variables (16, 48). The greater 
the volume and the lower the temperature of the injectate 
(i.e. the greater the difference in temperature between 
blood and the injectate) the greater is the signal-to-noise 
ratio. Thus, high volume, low temperature injectates have 
the best signal-to-noise ratios: nowever, the cold temp-
erature and the high volume can also affect cardiac output 
by altering heart rate and contractile force. Therefore, 
it was necessary to compromise in these experiments by 
using the smallest allowable volume (3 ~l) of ice-cold 
saline minimizing the problem of the volume of injection 
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(vhich may be a very important consideration under the low 
cardiac output, high pulmonary resistance state of endo-
toxin shock) while giving a reasonable signal-to-noise 
ratio. This does not, however, mitigate the problem of the 
rapid injection of ice-cold saline into the right atrium on 
the SA node or on AV nodal conduction. The continuous mon-
itoring of the EGG and of hemodynamic parameters during in-
jection provided some check on this problem. 
A second factor is the speed of injection (45, 60, 
62). All injections should be made smoothly and rapidly 
(Edwards Laboratories requires a speed no slower than 4 
ml/sec (26)). Injections which are too slow or not made at 
a uniform speed will not give true cardiac output readings. 
Reasonable care in making injections and attention 
to the factors which may affect cardiac output measurement 
by this technique results in measurements which correlate 
very ~ell with those made by the Fick principle (16) or 
with electromagnetic flow probes (169). Using either can-
nulating electromagnetic probes or periaortic probes, Pelle-
tier and associates (169) obtained correlation coefficients 
of 0.98 and 0.96, respectively, with the thermodilution 
technique using ice-cold injectates in dogs (?<0.001) in 
100 or more determinations. All of these determinations 
were made in control dogs under steady-state conditions. 
This raises one other consideration: During circulatory 
shock the cardiac output is no longer in a steady-state. 
There may be wide variations over a short period of time 
1•4n~ in differences between serial measurements of resu ..,.... o 
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greater than 5% and occasionally greater than 10%. ·While 
thiS may make individual measurements less accurate it is 
likely that trends over long periods of time will still be 
accurately reflected and that differences in the pattern 
between groups will still be faithfully recorded. Thus, 
the technique is still a useful tool even with the loss of 
accuracy under non-steady state conditions and has been 
found to be useful in critically ill patients under those 
conditions (45). Thus, thermodilution cardiac outputs are 
used to provide an index of flow in these experiments with-
out having to open the chest either acutely or during prior 
surgery to implant an electromagnetic flow meter. 
Summary 
To summarize, the following cardiovascular parameters 
are measured or calculated: Lead II electrocardiogram, 
heart rate, left ventricular pressure, left ventricular 
dP/dt, left ventricular stroke work, cardiac output, car-
diac index, pul~onary artery pressure, systemic arterial 
pressure, and systemic and pulmonary vascular resistance 
(calculated from the mean systemic and pulmonary arterial 
pressures and the cardiac index). 
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~·fetabolic Mea.su=ements 
Metabolic Measurements: Glucose 
-
Glucose was measured using the YSI model 26 Cantin-
uous Glucose Monitor. This instrument combines the elec-
tronics for the measurement of blood glucose by the glucose 
oxidase method with a peristaltic pump for the continuous 
withdrawal of the sample. Blood is withdrawn via a double 
lumen catheter which adds a small amount of heparin and 
sodium fluoride (both of which have been shown by Yellow 
Springs Instruments not to interfere with the glucose ox-
idase measurement (221)) via one lumen while the blood is 
being withdrawn via the other lumen at the rate of 2, 5, or 
10 ml/hr. The cannula for blood glucose sampling is placed 
by venipuncture in the left external jugular vein. Using 
this method of withdrawal there is no systemic anticoagu-
lation of the animal and there is only a slight dilution 
of the sample from this source which is controlled for by 
calibration using the same catheter system. Throughout most 
of the experiment the pump is on the slowest rate of with-
drawal so that only minimal volumes of blood are withdrawn 
for the measurement of glucose. During glucose clamping 
the 10 ml/hr speed is used to provide for better resolution 
of any changes in glucose level with time. The pump also 
introduces an appropriate amount of buf:er into the sample 
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chamber to dilute the sample and to maintain pH for the glu-
cose oxidase reaction. Glucose oxidase is immobilized on a 
~lutaraldehyde resin membrane. This layer is sandwiched 
d 
between a polycarbonate membrane on the outside facing the 
sample chamber with a pore size large enough to readily 
pass glucose, oxygen, and hydrogen peroxide, water, and 
salts and a cellulose acetate membrane on the inside facing 
the electrode with a pore size that excludes glucose, as-
corbic acid, and most interfering substances but which per-
mits the passage of hydrogen peroxide, water, and salts. 
The buffer also contains excess amounts of catalase to de-
stray any back-diffusing hydrogen peroxide. During the 
glucose oxidase reaction glucose combines with oxygen to 
form gluconic acid and hydrogen peroxide. The hydrogen 
peroxide then can diffuse across the inside of the mem-
brane to the electrode. At the electrode the hydrogen per-
oxide is oxidized creating a current which is proportional 
to the amount of hydrogen peroxide present in solution. 
Since hydrogen peroxide is produced in the glucose oxidase 
reaction in stoichiometric proportion to glucose consumed, 
the current is also related to the amount of glucose in the 
sample. Thus, the monitor can -- using appropriate cali-
bration (buffer -- i.e. 0 mg/dl -- and a 200 mg/dl standard 
were used for calibration and a nominal 500 mg/dl standard 
for a linearity check) -- then translate this current into 
glucose concentration in mg/dl. This method correlates well 
~ith other methods of measuring blood glucose (108). 
Metabolic Measurements: Insulin 
-
Using the radioimmunoassay technique, insulin was 
measured in serum samples taken every 15 min throughout 
the experiment from a catheter in the right femoral vein. 
Pharmacia Diagnostics Phadebas Insulin kits were used for 
this measurement. In this assay anti-insulin antibodies 
are immobilized on Sephadex beads. The radioimmunoassay 
technique employs the displacement of iodine-125 insulin 
from the antibodies by non-radioactive insulin from the 
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sample. This displacement occurs in a stoichiometric man-
ner such that the greater the insulin concentration in the 
sample the greater the amount of radiolabelled insulin which 
is displaced. The antibodies and any bound insulin are 
immobilized on Sephadex beads which can be sepa~ated from 
the supernatant solution. The remaining bound radioac-
tivity is quantified using a gamma counter. The counts 
obtained can then be related to the amount of insulin in 
the sample using appropriate standards to form a standard 
curve. ?or these experiments the standard curve and the 
samples are analyzed using a computer program developed 
by Kober and Yelich (see Appendix B) for the digital PDP 
12 computer utilizing a log-logit type analysis. Data is 
entered into the computer from the gamma counter using a 
paper type reader. The log-logit analysis Nas shown to 
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give values which correlate very well with those obtained 
bY reading off of the standard curve by hand. Correlation 
coefficients for the log-legit plots made by the computer 
were usually greater than 0.98 demonstrating the appropri-
ateness of the log-legit linearization technique.· Standard 
points which were off of the standard curve could be 
removed from the fit using an error correcting routine 
within the program. 'rtlhen the 0 uU/ml standard (H 0 ) was 
less than 15% of the total activity the kits no longer gave 
good results and the results were not used. The H0 standard 
for brand new kits was usually about 25% of the total ac-
tivity. This assay method has been shown by this laboratory 
to give reasonably good results with rat insulin (221). 
In addition, Pharmacia reports within and between assay co-
efficients of variation of approximately 5 to 10 per cent 
using human control sera. Initially the results with dog 
serum samples were found to be reasonable as well •. However, 
during the course of this study it has been discovered that 
under certain conditions spuriously high results may be ob-
tained (fasting control samples in the range of 100's to 
1000's of uiT/ml). Since others have had a similar problem 
(personal communication with Nancy Manson), this does not 
seem to be an isolated instance and may be a factor in the 
wide variability in the literature of the reported insulin 
levels in the endotoxic dog (14, 142, 198). ,., • l .. ~!le ~n-cerure~.~a-
tion of the insulin results included in this dissertation 
must, therefore, be made with a great deal of caution. 
This problem will be discussed further, where appropriate 
in the results and discussion sections. 
Metabolic Measurements: Lactate 
-
Deproteinized whole blood lactate samples obtained 
every fifteen minutes (from the right femoral vein) were 
precipitated in 0.8% perchloric acid (0.5 ml of sample in 
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1 ml of perchloric acid). The samples were then centrifuged 
to obtain the supernatant and lactate was determined with 
the Calbiochem-Behring Rapid Lactate kits using an enzy-
matic method. Samples were pooled into control (prior to 
endotoxin or saline injection), early (first half of time 
course) and late shock (second half of time course) samples 
for unclamped endotoxic dogs, and into postinjection clamp 
(15-120 min) and post clamp (135 min-termination of the 
experiment) samples for glucose clamped dogs. The assay 
method uses lactate dehydrogenase isolated from beef heart 
to convert the lactate to pyruvate while NAD is reduced to 
HADH. The reaction is driven to completion by adding glu-
tamate and glutamate-pyruvate transaminase to the reaction 
mixture. Thus, the pyruvate which is produced from lactate 
is converted to 1-alanine in the transamination reaction. 
The NADH absorbs light in the ultraviolet range at 340 nm. 
The NADH produced and consequently the lactate consumed can 
thus be determined by measuring the UV absorbance of the 
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samples after the reaction is driven to completion (60 min 
at J0°C). The reaction is buffered in pH 9.5 TRIS buffer. 
All samples were run in duplicate and an average of the 
two absorbance readings was taken as the reported values. 
The lactate concentration in the diluted samples is cal-
culated from the linear regression of a standard curve 
using the following standards (run singly with each assay): 
1) 0.44 mM, 2) 1.10 mH, 3) 2.20 mM, 4) 3.30 mM, and 5) 4.40 
mM. The linear regression and the calculation of sample 
concentrations including corrections of the concentration 
for the dilution of the original sample were performed on 
an HP97 calculator using a curve fitting program obtained 
from the Hewlett-Packard statistics package for the HP67/97. 
Summary 
To summarize the metabolic variables: Whole blood 
glucose, serum insulin, and deproteinized whole blood lac-
tate were measured as indices of the carbohydrate status. 
Arterial blood gases and pH were also measured in samples 
taken from the right femoral artery. 
Protocols 
Relationshin 2£ Hemodynamic Events i£ 
4etabolic Events during Endotoxin Shock 
trnclamned Studies 
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Following a 30 min control period in which measure-
ments were taken every 15 min (i.e. three control measure-
ments were taken) the animals were given either saline or 
endotoxin. All dogs were then monitored for 10 hrs or 
until death in the endotoxin group with measurements being 
made at the previously stated intervals. No other inter-
ventions were made in this set of unclamped experiments. 
Cardiovascular Function in the Endotoxic ~ during 
Altered Glycemic States Glucose Clamning Studies: ill Hyuoglycemic Clamu 
After 30 min control period all animals were given 
an intravenous bolus dose of insulin consisting of the fol-
lor,.;ing c·omponents: 80 U/kg of regular insulin, 18 U/kg 
LENTE insulin, and 9 U/kg ULTRALENTE insulin. An infusion 
via the left femoral vein was also started at this time at 
2 ~1/min of 5 U/ml of regular insulin. This infusion was 
maintained at this rate until the desired level of blood 
glucose was reached. After 45 min the blood glucose had 
dropped to 27±2 mg/dl. At this time dogs were given ..... , e~~.ner 
saline or 8 mg/kg endotoxin. The blood glucose was then 
maintained at a mean level between 10 and 30 mg/dl (19.7 
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~o.B mg/dl) for a period of 2 hrs with intermittent infu-
sions of 5 U/:nl regular i-nsulin at 2 ml/min or 5% glucose 
(glucose was given on an empirical basis -- usually 10•20 
ml were given over a period of about a minute) as needed. 
These doses and infusion rates of insulin and glucose were 
chosen by trial-and-error in order to reach and maintain 
the desired level of blood glucose. Because the hypo-
glycemic clamp places considerable stress on the animal and 
consequently leads to powerful reflexes to return the blood 
glucose back to normal, even these doses of insulin proved 
inadequate in some animals to maintain the clamp -- par-
ticularly over the first hour of the clamp in endotoxic 
animals. Dogs (N=5) in which the clamp could not be main-
tained for 2 hrs were excluded from the study. After the 
2 hr period all animals were monitored for an additional 
3 hrs or until death without further infusions. 
Cardiovascular Function iQ ~ Endotoxic ~ during 
Altered Glycemic States -- Glucose Clamning Studies: 
~ llormo.glycemic Clamn 
After a 30 min control period an infusion of 5 U/ml 
regular insulin was started at a rate of 1 ml/min along with 
an infusion of 50% glucose at a rate of 1 ml/min (both in-
fusions were given through a catheter in the left femoral 
Vein). These infusions were then periodically adjusted by 
trial-and-error to maintain blood glucose at a mean level 
between 75 and 95 mg/dl (85±1 mg/dl). After 45 min the 
dose of saline or endotoxin was administered as described 
previously. The clamp was maintained for 2 hrs posteno-
toxin or saline injection after which all infusions were 
stopped. All dogs were then monitored for another 6 hrs 
after ending the clamp or until death in the endotoxic 
group. 
cardiovascular Function ~ ~ Endotoxic Dog during 
Altered Glycemic States Glucose Clamning Studies: 
The Hv-oerglycemic Cla:n-o 
-
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Following a 30 min control period animals were given 
a bolus dose of 300 mg/kg glucose (20% glucose in water). 
At the same time an infusion via the left femoral vein of 
50% glucose was started at 1 ml/oin. The infusion rate was 
adjusted periodically to maintain blood glucose at a mean 
level between 145 and 165 mg/dl (156±3 mg/dl); these ad-
justments were made by trial-and-error to achieve the de-
sired level of blood glucose. Infusions were maintained 
over the same period of time as for the hypoglycemic clamp. 
Forty-five minutes after giving the bolus dose of glucose, 
animals were given either saline or 8 mg/kg endotoxin. T~e 
clamp was maintained for 2 hrs after the injection of saline 
or endotoxin and then all infusions were stopped and the 
dogs were monitored for an additional 8 hrs or until death. 
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~ Analysis 
In the unclamped experiments data were divided into 
a control and a post injection period. Because of the var-
iable time course of endotoxin shock, the post-injection or 
post-saline injection time course was normalized as a per-
centage of the time to death or the end of the experiment in 
the unclamped groups. This normalization device allowed the 
comparison of animals in what is assumed to be similar path-
ophysiological states. The data points obtained from the 
normalization procedure were then used for statistical com-
parisons. Statistical comparison between groups in the un-
clamped experiments was made using a factorial analysis of 
variance. Significant differences between groups were iden-
tified using a modified t-test at the various points. 
In the glucose clamping experiments data were grouped 
into a control (-75 to -45 -- i.e. prior to any experimen-
tal manipulations), a preinjection clamp (0 min-- i.e. 
after the glucose clamp is established but prior to saline 
or endotoxin injection), a postinjection clamp (15 to 120 
mi~ -- i.e. during glucose clamping after the injection of 
saline or endotoxin), and a postclamp period (>120 min 
i.e. after the infusions are stopped). Data from each dog 
were averaged over each period of time and the resulta~t 
means were taken as representative data points for each 
tim.e period. l1easurements taken just prior to tne end 
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o£ the experiment were also compared (for some parameters 
such as systemic and pulmonary resistance this was not done 
since some or all of the animals in the endotoxin groups 
died during the course of the experiment). Statistical 
comparisons were made using a one-way analysis of variance 
to determine the effect of the three clamps in saline and 
endotoxin injected animals. Significant differences be-
tween groups were identified using a modified t-test. 
CHAPTER V 
RESULTS 
!£! Unclamped Experiments 
A total of 21 dogs, 5 saline-injected and 16 endo-
toxin-injected, were used in this set of experiments. As 
can be seen from figure 1, the endotoxic group can be divi-
ded into a group of 6 dogs which showed an early hypergly-
cemic phase and a group of 10 dogs which showed no hyper-
glycemic phase during continuous blood glucose monitoring. 
While such an arbitrary division can perhaps be made using 
other criteria, glucose is the parameter of interest in 
this study and, thus, it is of interest to make the division 
in this case based on differences in the pattern of glucose 
dyshomeostasis following the administration of endotoxin. 
This difference in the pattern of changes in blood glucose 
is readily apparent in the records of the individual animals 
(see Appendis A, fig. 20) and it is therefore easy to make 
this kind of division of the endotoxic dogs into two groups. 
Statistical analysis clearly demonstrates that all three 
groups of dogs (control and the two endotoxic groups) had 
different patterns of blood glucose levels (?<0.05). The 
peak glucose level in the hyperglycemic group of 114±10 
mg/dl occurred at 40±5 min following the administration of 
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Fig. 1. Glucose -- Unclamned Exneriments: Saline ( 0, N=5), Endot;xin w~hyper~lycemia (X, N=6), 
Endotoxin w/no hyperglycemia (~, N=10). All 
three groups exhibit different patterns of 
blood glucose (P<0.05). 
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endotoxin (at approximately 10 per cent of the average time 
course of 398±72 min in the hyperglycemic, endotoxin group 
of dogs). The mean time of survival of endotoxic dogs-not 
showing any hyperglycemic stage was 276±47 min. Using an 
unpaired t-test this is not significantly different from 
the hyperglycemic group although the trend is toward short-
er survival times (t=1.3874 with 14 degrees of freedom, 
p:0.094). This probably is a reflection of the highly 
lethal model of endotoxin shock used in these experiments. 
Near death, both groups of endotoxic dogs were profoundly 
hypoglycemic (10±4 mg/dl in dogs exhibiting an initial 
hyperglycemic phase and 9±3 mg/dl in dogs showing no hyper-
glycemia). In contrast glucose was fairly well maintained 
over a 10 hr period in dogs given saline. 
The serum immunoreactive insulin levels are shown in 
figure 2. There were no significant differences in insulin 
levels between any of the three groups at any point. 
There was a high degree of animal-to-animal variability in 
the endotoxic groups as demonstrated by the large standard 
errors in these two groups (see also fig. 21, Appendix A). 
This high degree of variability probably reflects the highly 
variable time course of changes in insulin levels seen in 
endotoxic animals. These results are indicative of at least 
a functional hyperinsulinemia in the endotoxic dog. These 
results, however, must be viewed with a certain amount of 
caution in light of the previously mentioned problem with 
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Fig. 2. Insulin -- Unclamped Experiments: Saline ( 0, N=5), Endotoxin w/hyper~lycemia (X, N=6), 
Endotoxin w/no hyperglycemia l6, N=10). 
No significant differences between groups. 
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spuriously high insulin levels obtained in other experiments 
(see results of glucose clamping experiments). The fasting 
control level of 27±6 uU/ml obtained with this group of 21 
dogs is certainly reasonable and while the elevations seen 
in some cases following the administration of endotoxin are 
dramatic (highest individual insulin measurement: 300 uU/ml) 
they are not unreasonable none of the measured control 
or experimental values in the unclamped series of dogs was 
higher than the highest standard concentration, in contrast 
to the results in the glucose clamping experiments. Because 
of the problem encountered in assaying the samples from the 
glucose clamping experiments, these results in unclamped 
animals cannot be taken as conclusive proof of hyperinsuli-
nemia in the endotoxic dog. 
Tables I, II, and III show the arterial blqod gas and 
pH data for the unclamped experiments while the plasma lac-
tate data is included in Table VIII along with the lactate 
data from the glucose clamping experiments. No consistent 
changes in either arterial P02 or PC0 2 were seen in either 
group of endotoxic dogs. Both groups of endotoxic dogs be-
came acidotic, but there was no difference in the degree of 
acidosis seen in either group. Lactate was elevated in the 
9 endotoxic dogs in this group in which these measurements 
were made. Insufficient samples, however, were taken from 
dogs showing hyperglycemia (N=2) to make a comparison of 
lactate levels in the two endotoxic groups. The similarity 
Saline 
( 5) 2 
Table I Arterial pH -- Unclamped Studies 
Control 
7.39±0.03 7.39±0.03 
Late 1 
Endotoxin 
l-t/hyperglycemia 
7.09±0.06 4 
(4)2 
Endotoxin 
no hyperglycemia 
(8)2 
1: Early= 0-25% of postinjection time course, Mid= 25-75%, Late= 75-100% 
2: (N) 
3: N=17 for Control 
4: Significantly different from saline, P<0.05 
Saline 
( 5) 2 
Endotoxin 
u/hyperglycemia 
(4)2 
Endotoxin 
no hyperglycemia 
(8)2 
'l'able II Arterial 
Control 
85 ±4 3 
P02 -- Unclamped Experiments 
P02 ~mmllg) 
Early 1 Mid 1 Late 1 
77 ±2 It 74±3 .. 71 ±4 It 
63±10 4 57 ±11 It 55±9 4 
1: Early= 0-25% of postinjectlon time course, Mid= 25-75%, Late= 75-100% 
2: ( N) 
3: N=17 for control measurement 
4: No significant differences 
'I'able 
Saline 
( 5) 2 
Endotoxin 
w/hyperglycemia 
( 4) 2 
Endotoxin 
no hyperglycemia 
(8)2 
III Arterial PC02 
PC0 2 
Control 
33 ±2 3 
--
Unclamped Experiments 
(mmHg) 
Early 1 Mid 1 Late 1 
33 ±1 .. 30±2 .. 29 ±1 It 
39±4 It 42±4 .. 47±5 .. 
27±2 .. 30±6 .. 36±4 .. 
1: Early- 0-25% of postinjection time course, Mid= 25-75%, Late= 75-100% 
2: ( N) 
3: N=17 for Control 
4: No significant differences 
of pH in these dogs, however, is an indication that these 
levels would probably not be different. 
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Cardiac output is plotted in figure 3. The cardiac 
output fell rapidly after the administration of endotoxin 
and remained below control levels throughout the time course 
of shock in both groups of endotoxic dogs. The cardiac out-
out in endotoxic dogs going through an early hyperglycemic 
... 
phase tended to be higher than that seen in endotoxic dogs 
with no early sign of hyperglycemia. However, both groups 
of endotoxic dogs gradually approached the same end-point. 
Both peak left ventricular systolic and end-diastolic 
pressures are plotted in figure- 4. While peak pressure was 
below control in both"endotoxic groups throughout the time 
course of shock, there were no differences between the two 
groups of endotoxic dogs. However, end-diastolic pressure 
fell to a greater extent in animals which demonstrated an 
early hyperglycemic phase. 
Stroke work is shown in figure 5. Stroke work was 
markedly depressed below control levels throughout the 
course of endotoxin shock in both groups of endotoxic dogs. 
Following a pattern similar to that for cardiac output, 
dogs which showed no hyperglycemia performed significantly 
less cardiac work than did dogs which went through an 
initial hyperglycemic phase. 
~fean systemic blood pressure is shown in +'1.· :t'U,.."' o~" 
- '=> --
and calculated total peripheral resistance is shown in 
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Fig. ). Cardiac Output -- Unclamped Experiments: 
Saline ( 0, N=5), Endotoxin w/hyperglycemia 
(X, N=5), Endotoxin w/no hyperglycemia 
(~, N=10). 0 P<0.05 compared to control; 
* P<0.05 compared to control and endotox 
w/hyperglycemia; 0 P<0.05 compared to 
control, P<0.1 comnared endotoxin 
w/hyperglycemia. • 
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Fig. 4. Left Ventricular Peak Systolic and 
End-diastolic Pressures -- Unclamped 
Experiments: Saline ( 0, N=5), Endotoxin 
w/hyperglycemia (X, N=6), Endotoxin w/no 
hyperglycemia (~, N=10). Peak systol~c 
pressure -- endotoxin groups less than 
control, no differences between endotoxin 
groups. End-diastolic pressure -- endotoxin 
groups less than control, endotoxin 
w/hyperglycemia less than endotoxin w/no 
hyperglycemia. 
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Fig. 5. Left Ventricular Stroke Work -- Unclamped 
Experiments: Saline ( 0, N=5), Endotoxin 
w/hyperglycemia (X, N=5), Endotoxin w/no 
hyperglycemia(~, N=10).*P<0.05 compared 
to control;*P<0.05 compared to control and 
endotoxin w/hyperglycemia;OP<0.05 compared 
to control, ?<0.1 compared endotoxin 
w/hyperglycemia. -
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Fig. 6. Mean Systemic Arterial Pressure -- Unclamped 
Experiments: Saline ( 0, N=5), Endotoxin 
w/hyperglycemia (X, tl=6), Endotoxin w/no 
hyperglycemia (1:1, N=10). o P<0.05 compared 
to control; * P<O. 05 com-oared to control 
and endotoxin w/hyperglycemia; 0P<0.05 
compared to control, P<0.1 compared 
endotoxin w/hyperglycemia. 
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£igure 7. Blood pressure fell to a similar extent in both 
groups of endotoxic dogs. As would be expected from the 
similar blood pressure but lower cardiac output seen in 
dogs which did not show an initial hyperglycemia, total 
peripheral resistance became progressively more elevated 
in this group than in either control dogs or endotoxic dogs 
exhibiting the hyperglycemic phase. These differences were 
particularly striking late during the course of endotoxin 
shock. A remarkably similar pattern was seen in the pul-
monary circulation as shown in figures 8 and 9. 
Glucose Clamning Experiments 
A total of 25 dogs were included in these experi-
ments: 5 hypoglycemic-clamped saline-injected dogs, 6 hypo-
glycemic-clamped endotoxin-injected dogs, 3 normoglycemic-
clamped saline-injected dogs, 4-normoglycemic-clamped endo-
toxin-injected dogs, 3 hyperglycemic-clamped saline-injected 
dogs, and 4 hyperglycemic-clamped endotoxin-injected ani-
mals. In all of the figures the hypoglycemic clamp data is 
on the bottom, normoglycemic clamp in the middle, and hyper-
glycemic clamp data on the top. Dark bars represent data 
from endotoxin-injected dogs. ?reinjection data includes 
all dogs in a particular clamp group. (11 hypoglycemic-
clamped dogs, 7 normoglycemic-clamped dogs, and 7 hyper-
glycemic-clamped dogs.) 
In the hypoglycemic clamp experiments the average 
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Fig. 7. Total Peripheral Resistance -- Unclamped 
Exneriments: Saline ( 0 , N=5), Endotoxin 
w/hyperglycemia (X, N=5), Endotoxin w/no 
hyperglycemia (d, N=10). * P<0.05 compared 
to control; * P<0.05 comnared to control 
and endotoxin w/hyperglyc~mia; 0 P<0.05 
comnared to control, ?<0.1 comnared 
endotoxin w/hyperglycemia. · 
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Fig. 8. Mean Pulmonary Artery Pressure -- Unclamped 
Experiments: Saline ( 0, N=5), Endotoxin 
w/hyperglycemia (X, N=4), Endotoxin w/no 
hyperglycemia (~, N=8). * P<0.05 compared 
to control; * P<0.05 compared to control 
and endotoxin w/hyperglycemia; 0 P<O. 05 
compared to control, ?<0.1 compared endotoxin 
w/hyperglycemia. 
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Fig. 9 Pulmonary Resistance -- Unclamped Experiments 
Saline ( 0, N=5), Endotoxin w/hyperglycemia 
(X, N=4), Endotoxin w/no hyperglycemia 
(A, N=8), * P<0.05 compared to control: 
* P<0.05 compared to control and endotoxin 
w/hyperglycemia; 0 P<0.05 compared to 
control, P<0.1 compared endotoxin 
w/hyperglycemia. 
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time of survival for endotoxic dogs was 140z4 min following 
endotoxin administration. There were also 2 deaths in the 
hypoglycemic-clamped saline-injected group at 195 and 254 
min• All normoglycemic-clamped saline-injected animals were 
alive at 480 min post-injection while the mean survival time 
in endotoxic normoglycemic-clamped dogs was 323z32 min. All 
hyperglycemic-clamped saline-injected dogs were also alive 
at the termination of the experiment (600 min) while there 
was one death in the endotoxic hyperglycemic-clamped group 
prior to 600 min (249 min post endotoxin). Thus, while 
hypoglycemia significantly shortened survival (P<0.0001) 
when compared to unclamped endotoxic animals (318!41 min), 
hyperglycemia markedly prolonged survival (P=0.01) and 
normoglycemia did not affect survival time (P=0.48). 
Figure 10 shows the glucose levels in the three types 
of clamps (see also fig. 24, Appendix A). There were no 
significant differences in the glucose levels during the 
preclamp control period. All three groups were different 
during the preinjection clamp period (P<<0.001). There-
spective saline- and endotoxin-injected groups for each of 
the three clamps were maintained at similar levels during 
the postinjection clamp period (P~0.2) and the three clamp 
levels were all significantly different from each other 
(P<<0.001). Following the clamp the normoglycemic-clamped 
endotoxin-injected dogs dropped to blood glucose levels 
similar to the hypogly~emic-clamped dogs while three out 
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Fig. 10. Glucose -- Glucose Clamping Experiments: 
Control and ?reinjection Clamp --
Hyperglycemia (~=7), Normoglycemic (N=7), 
Hypoglycemic (N=11). Postinjection --
light bars=saline and dark bars=endotoxin. 
Hyperglycemic saline (N=J), Hyperglycemic 
endotoxin (N=4), Normoglycemic saline 
(N=J), Normoglycemic endotoxin (N=4), 
Hypoglycemic saline (N=5), Hypoglycemic 
endotoxin (N=6). Refer to text for 
comparison of groups. 
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of the four hyperglycemic-clamped endotoxic dogs also became 
hypoglycemic (one dog remaining normoglycemic). These 
trends continued to the end of the experiments. Normogly-
eemic-clamped saline-injected dogs fell to glucose levels 
slightly below control levels and then returned to control 
levels prior to the termination of the experiment. Hyper-
glycemic-clamped saline-injected dogs fell back to control 
levels or slightly higher and remained there until the end 
of the experiment. 
Problems with the insulin assay prevent the reporting 
of reliable insulin data for the glucose clamping groups. 
Fasting control levels ranged from 5 to 1410 uU/ml (mean 
zSD: 253.84±306.97 for 106 samples). This contrasts with 
control samples obtained during the unclamped experiments 
which averaged 27.27±21.97 for 261 control samples. A dog 
serum reference sample measured concurrently with the sam-
ples from the glucose clamping experiments ranged from 215 
to 427 in 10 different assays giving a coefficient of var-
iation of 24.6% in contrast to the Pharmacia interassay var-
iation of 5-10% in human control sera as reported in their 
brochure. Assay-to-assay coefficients of variation ranging 
from 11.8% to 70% were also obtained on fasting control 
sampl~s from the glucose clamping experiments when several 
repeat measurements were made. In two out of the three 
hyperglycemic clamp control dogs measured insulin levels 
remained elevated even 8 hr following cessation of glucose 
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infusion (100-600 uU/ml). Furthermore, despite the main-
tenance of normal glucose levels.in normoglycemic-clamped 
saline-injected animals up to 6 hr after glucose and insu-
lin infusions were stopped, levels were measured in the 
1ooo's of uU/ml. Dilution of the dog reference serum sam-
ple in the manner of a standard curve resulted in a reason-
able standard curve; therefore, it seems likely that the 
interfering factor is specific for insulin antibodies. 
The source of this interference is not completely known. 
Glucose and insulin infusion rates for these experi-
ments are shown in Table IV. There were no differences in 
glucose infusion rates between corresponding saline and en-
dotoxin groups but the glucose infusion rates increased 
significantly with the clamp level. This lack of statis-
tically significant differences between saline and endo-
toxic dogs, however, is somewhat misleading since only 
one out of five saline-injected dogs in this clamp group 
required any glucose to maintain the clamp level. In 
contrast all six of the endotoxic dogs in this group re-
quired varying amounts of glucose. While these infusion 
rates have not been corrected for errors from the "desired" 
level, lacking information as to the glucose space in the 
endotoxic dog such correction was not possible. In prac-
tice it became necessary to vary the insulin infusion in 
the normoglycemic clamp as well as the glucose infusion. 
The insulin infusion rates were significantly higher in the 
Table IV Infusion Rates -- Glucose Clamping Experiments 
Hyperglycemic Clamp 
Saline (3) 1 
Endotoxin (4) 1 
Normoglycemic Clamp 
Saline (3) 1 
Endotoxin (4) 1 
Hypoglycemic Clamp 
Saline (5) 1 
Endotoxin (6) 1 
1 : ( N) 
Glucose 
(mg/Kg/min) 
6.72±1.38 2 
8.68±0.98 2 
4.72±1.30 3 
4.11±0.53 3 
0.23±0.23'* 
0.99±0.33'* 
Insulin 
(U/Kg/min) 
0.27±0.07 
0.66±0.09 5 
4.51±0.43 
3.49 0.88 
2, 3, 4: significant differences between clamps, P<0.05; no significant 
differences between endotoxin and corresponding saline group 
5: significantly different from corresponding saline group, P<0.05 
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do toxic normoglycemic·clamped dogs than in the corre· en -
sponding controls. There werep however, no differences in 
the insulin infusion rates between the two groups of hypo-
glycemic-clamped dogs. 
The arterial blood gas and pH data and the plasma 
lactate levels in the clamp groups are presented in Tables 
v through VIII. There was some tendency for the hypogly-
cemic-clamped groups to become hypoxic, although this was 
not significant. These groups also became significantly 
hypercapnic during the course of the experiment. No other 
consistent differences in arterial P02 and PC02 were found. 
All three endotoxic groups as well as hypoglycemic-clamped 
saline·injected dogs became acidotic ·- hypoglycemic clamped 
endotoxin dogs to the greatest degree and the other three 
groups to about the same level. The plasma lactate levels 
are consistent with these results suggesting that the aci-
dosis in all four groups was at least in part due to the 
lactacidemia. 
Cardiac output is plotted in figure 11. There were 
no differences during the control or preinjection clamp 
periods. Following the injection of endotoxin all endo-
toxic dogs fell to similar levels while all three saline-
injected groups remained at control levels. Following the 
clamp there was a further deterioration in the cardiac 
output in hypoglycemic-clamped endotoxin-injected dogs 
while all other groups essentially remained at the same 
'!'able V Arterial pH 
--
Glucose Clamping Experiments 
.E.!! 
... Control 1 Preinj 1 Postinj 
Clamp Clamp 
Hyperglycemic Clamp 
Saline ( 3 )2 7.39±0.01 7.41±0.02 7.40±0.02 
Endotoxin (4)2 7.22±0.03 3 
Normoglycemic Clamp 
Saline ( 3 )2 7.36±0.0J 7.37±0.03 7.35±0.07 
Endotoxin (4):i: 7.19±0.05 3 
Hypoglycemic Clamp 
Saline ( 5 )2 7.34±0.02 7.31±0.03 7.19±0.05 3 
Endotoxin (6)2 ?.09±0.03 .. 
1: for control and preinjection clamp-- Hyperglycemic clamp. N=?; 
Norrnoglycemic clamp, N=?; Hypoglycemic clamp, N=11 
2: (N) 
Post Clamp 
7.36±0.02 
7.23±0.06 3 
7.37±0.06 
7.16±0.04 3 
7.16±0.04 3 
6.99±0.04 .. 
3: significantly different from hyperglycemic and normoglycemic clamp salirie, P<0.05 
4: significantly different from all other groups, P<0.05 
, Table VI Arterial P0 2 -- Glucose Clamping Experiments 
,. 
Hyperglycemic Clamp 
Saline (3) 2 
Endotoxin (4) 2 
Normoglycernic Clamp 
Saline (3) 2 
Endotoxin ( 1~) 2 
Hypoglycemic Clamp 
Saline (5) 2 
Endotoxin (6) 2 
Control 1 
85±3 
?8±4 
93±2 
P02 { mmllg} 
Preinj 1 
Clamp 
95±4 
92±6 
96±4 
Postinj 
Clamp 
95±5 3 
?3±4 
83±1 0 
82±4 
?4±4 
?1 ±4 
Post Clamp 
85±4 
?3±8 
?8±9 
??±4 
66±5 
5?±? 
1: lfyperglycemic Clamp, N=?; Normoglycemic Clamp, N=?; Hypoglycemic Clamp, N=11 
2: ( N) 
3: not significantly different from Normoglycemic saline (P=O.O?), significantly 
different from all other groups (P<0.05); no other significant differences 
Table VII Arterial PC0 2 -- Glucose Clamping Experiments 
PC0 2 (mmHg) 
Control 1 Preinj 1 
Clamp 
Postinj 
Clamp 
Post Clamp 
Hyperglycemic Clamp 
Saline (3) 2 
Endotoxin (4) 2 
Normoglycemic Clamp 
Saline (3) 2 
Endotoxin (4) 2 
Hypoglycemic Clamp 
Saline (5) 2 
Endotoxin (6) 2 
30±2 
33±3 
35±4 
34±3 
28±2 
32±3 
29±7 
35 ±1 
33±4 
29±2 
48±6 3 
43±4 .. 
26±2 
33±4 
57±4 3 
61 ±5 3 
1: llyperglycemic Clamp, N=7; Normoglycemic Clamp, N=7; Hypoglycemic Clamp, N=11 
2: ( N) 
3: 
4: 
significantly different from all other groups, P<0.05 
significantly different from Hyperglycemic saline and Normoglycemic 
endotoxin, P<0.02 
5: significantly different from Normoglycemic saline, P=0.05 
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Table VIII Plasma Lactate 
Lactate (mmol/1) 
Unclamped Glucose Clamping 
Postinj Post Clamp 
Clamn 
Control ( 14) l 0.93±0.09 
Early Shock ( 9) l 3.20±0.50 2 
Late Shock ( 9) l 4.20±0.70 2 
Hyperglycemic Clamp 
Saline ( 3) l 1.30±0.20 0.70±0.20 
Endotoxin ( 4) l 1.50:t0.20 3 2.20:t0.10 3 
Normoglycemic Clamp 
Saline (3)1 1.20:t0.10 1.40±0.10 5 
Endotoxin ( 4) l 2.00±0.20 3 2.50:t0.20 3 
Hypoglycemic Clamp 
Saline ( 5) l 1.30:t0.20 1.70±0.30 6 
Endotoxin (6)1 2.90±0.201+ 3.50±0.301+ 
1 : (N) 
2: early shock = 0-50% of postinjection time course; late 
shock = 50-100%; significantly different from control 
by unpaired t test, P<0.001 
3: significantly different frpm saline-injected clamp 
groups and from control, P.<O. 05 
4: significantly different from all other groups, P<0.05 
5: significantly different from all groups except Hypo-
glycemic saline, P<0.05 
6: significantly different from all other groups except 
Hyperglycemic endotoxin, P<0.05 
Fig. 11. Cardiac Output -- Glucose Clamping 
Experiments: Control and ?reinjection 
Clam~ -- Hyperglycemic (N=7), Normoglycemic 
(N=7), Hypoglycemic (N=11). Postinjection 
light bars=saline and dark bars= 
endotoxin. Hyperglycemic saline (N=J), 
Hyperglycemic endotoxin (N=4), 
Normoglycemic saline (N=J), Normoglycemic 
endotoxin (N=4), Hypoglycemic saline (N=5), 
Hypoglycemic endotoxin (N=6). Refer to 
text for comparison of groups. *All 
animals in these two groups were dead at 
the end of the experiment. 
1 01 
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levels as during the clamp. Subsequently all of the hypo-
glycemic- and normoglycemic-clamped endotoxin-injected 
dogs died while the hypoglycemic-clamped saline-injected 
and the hyperglycemic-clamped endotoxin-injected dogs fell 
to similar levels. The normoglycemic-clamped and hypergly-
cemic-clamped saline-injected animals remained at control 
levels throughout the experiment. 
Left ventricular peak systolic pressure (figure 12) 
and left ventricular end-diastolic pressure (figure 13) 
are shown in the next two figures. During the preinjection 
clamp period the hypoglycemic-clamped dogs began to fall to 
lower peak systolic pressures. With the injection of endo-
toxin left ventricular predsure fell to the same extent in 
all three endotoxin-injected groups. During the clamp the 
left ventricular peak systolic pressure continued to fall 
in the hypoglycemic-clamped saline-injected dogs but not to 
the same extent as any of the endotoxic groups. Following 
the clamp period left ventricular pressure continued to 
fall in the hypoglycemic-clamped endotoxic group but re-
mained about the same in the other two endotoxic groups. 
The hypoglycemic-clamped saline group continued to decline 
but was still higher than any of the three endotoxic groups. 
Prior to the termination of the experiment left ventricular 
pressure was similar in the hypoglycemic-clamped saline-
injected dogs and the hyperglycemic-clamned dogs while 
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Fig. 12. Left ventricular Peak Systolic Pressure --
Glucose Clamping Experiments: Control and 
Preinjection Clamp -- Hyperglycemic (N=7), 
Normoglycemic (N=7), Hypoglycemic (N=11 ), 
Postinjection -- light bar~=saline and 
dark bars=endotoxin. Hyperglycemic saline 
(N=3), Hyperglycemic endotoxin (N=4), 
Normoglycemic saline (N=3), Normoglycemic 
endotoxin (N=4), Hypoglycemic saline (N=5), 
Hypoglycemic endotoxin (N=6). Refer to 
text for comparisons of groups. *All 
animals in these two groups were dead at 
the end of the experiment. 
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Fig. 13. Left Ventricular End-diastolic Pressure --
Glucose Clamping Experiments: Control and 
Preinjection Clamp-- Hyperglycemic (N:7), 
Normoglycemic (N:7), Hypoglycemic (N:11). 
Postinjection -- light bars:saline and dark 
bars:endotoxin. Hyperglycemic saline (N=J), 
Hyperglycemic endotoxin (N:4), Normoglycemic 
saline (N=3), Normoglycemic endotoxin (N=4), 
Hypoglycemic saline (N:5), Hypoglycemic 
endotoxin (N=6). Refer to the text for 
comparisons of groups. *All animals in 
these two groups were dead at the end of the 
experiment. 
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the remaining endotoxic dogs all died. Left ventricular 
pressure remained fairly steady throughout the experiment 
in the normoglycemic- and hyperglycemic-clamped saline~ 
injected control dogs. There were no differences in left 
ventricular end-diastolic pressures until just prior to 
the termination of the experiment in any of the groups. 
This is probably due to the quantity of fluid infused du-
ring the glucose clamps since end-diastolic pressure fell 
in unclamped dogs. 
A similar pattern of events was also seen for stroke 
work. shown in figure 14, with the exception that hypogly-
cemic~clamped saline-injected dogs did not fall to the same 
extent as hyperglycemic-clamped endotoxic dogs. Otherwise, 
cardiac work deteriorated most rapidly in hypoglycemic-
clamped endotoxin dogs, followed by nor~oglycemic-clamped 
and then hyperglycemic-clamped endotoxic dogs. Normogly-
cemic- and hyperglycemic-clamped saline-injected dogs re-
mained at control levels throughout the experiment. 
Figures 15 and 16 show the mean systolic blood 
pressure and the total peripheral resistance respectively. 
Systemic arterial pressure followed a similar pattern in 
all groups as for the cardiac performance parameters. 
While qualitatively the systemic resistance seems to fol-
low the same pattern in hypoglycemic-clamped endotoxic 
dogs as for unclamped dogs not exhibiting a hyperglycemic 
=hase, there were no significant differences among any 
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Fig. 14. Left Ventricular Stroke Work -- Glucose 
Clamping Experiments: Control and 
Preinjection Clamp -- Hyperglycemic (J=7), 
Normoglycemic (N=7), Hypoglycemic (N=11). 
Postinjection -- light bars=saline and dark 
bars=endotoxin. Hyperglycemic saline (N=J), 
Hyperglycemic endotoxin (N=4), Normoglycemic 
saline (N=J), Normoglycemic endotoxin (N=4), 
Hypoglycemic saline (N=5), Hypoglycemic 
endotoxin (N=6). Refer to the text for 
comparisons of groups. *All animals in 
these two groups were dead at the end of 
the experiment. 
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Fig. 15. Mean Systemic Arterial Pressure -- Glucose 
Clamping Experiments: Control and 
Preinjection Clamp-- Hyperglycemic (N=7), 
Normoglycemic (N=7), Hypoglycemic (N=11), 
Postinjection -- light bars=saline and 
dark bars=endotoxin. Hyperglycemic saline 
(N=J), Hyperglycemic endotoxin (N=4), 
Normoglycemic saline (N=J), Normoglycemic 
endotoxin (N=4), Hypoglycemic saline (N=5), 
Hypoglycemic endotoxin (N=6). Refer to 
text for comparisons of groups. *All animals 
in these two groups were dead at the end of 
the experiment. 
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Fig. 16. Total Peripheral Resistance -- Glucose 
Clamping Experiments: Con~rol and 
?reinjection Clamp -- Hyperglycemic (~~7), 
Normoglycemic (N=7), Hypoglycemic (N=11). 
Postinjection -- light bars=saline and 
dark bars=endotoxin. Hyperglycemic saline 
(N=3), Hyperglycemic endotoxin (H=4), 
Normoglycemic saline (N=3), Normoglycemic 
endotoxin (N=4), Hypoglycemic saline (N=5), 
Hypoglycemic endotoxin (N=6). Refer to 
text for comparisons of groups. 
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of the groups at any of the time points. This is probably 
due to the high variability of the calculated resistance 
in general and the highly variable response of the other 
two endotoxic groups. 
Figures 17 and 18 show the mean pulmonary artery 
pressures and the pulmonary resistance. There were no sig-
nificant differences in mean pulmonary resistance. There 
were no significant differences in mean pulmonary artery 
pressure in any of the groups through the glucose clamping 
period. Following the clamp, however, pressure started to 
fall in all three endotoxic groups and the hypoglycemic-
clamped saline-injected group. The pattern was similar at 
the termination of the experiment to that seen for all of 
the other cardiovascular parameters. Pulmonary artery re-
sistance was significantly higher than any o£' the other 
groups during the postclamp period in hypoglycemic-clamped 
endotoxic dogs. Thus, pulmonary resistance in these animals 
followed a pattern reminiscent of the unclamped endotoxic 
dogs showing early hyperglycemia. 
Summary of Results 
To summarize the results: Two patterns of glucose 
changes were seen in unclamped endotoxic dogs. One group 
of dogs showed initial hyperglycemia while the other did 
not. Bo t.n· ...... atterns e1'" · + d · t' h ~ v w _e assoc~ave w~ a .yperinsulinemia. 
11 5 
Fig. 17. Mean Pulmonary Artery Pressure -- Glucose 
Clamping Experiments: Control and 
?reinjection Clamp -- Hyperglycemic (N=7), 
Normoglycemic (N=7), Hypoglycemic (N=11). 
Postinjection -- light bars=saline and dark 
bars=endotoxin. Hyperglycemic saline (N=3), 
Hyperglycemic endotoxin (N=4), Normoglycemic 
saline (N=3), Normoglycemic endotoxin (N=4), 
Hypoglycemic saline (N=5), Hypoglycemic 
endotoxin (N=6). Refer to text for 
comparisons of groups. *All animals in 
these two groups were dead at the end of 
the experiment. 
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Fig. 18. Pulmonary Resistance -- Glucose Clamping 
Experiments: Control and Preinjection 
Clamp -- Hyperglycemic (N=7), Normoglycemic 
(N=7), Hypoglycemic (N=11). Postinjection 
-- light bars=saline and dark bars=endotoxin. 
Hyperglycemic saline (~=3), Hyperglycemic 
endotoxin (N=4), Normoglycemic saline (N=3), 
Normoglycemic endotoxin (N=4), ~ypoglycemic 
saline (N=5), Hypoglycemic endotoxin (N=6). 
Refer to the text for comparisons of groups. 
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Cardiac output and stroke work tended to be better in dogs 
exhibiting early hyperglycemia. While left ventricular 
pressure was similar in both groups of endotoxic dogs, -an-
imals showing the initial hyperglycemic phase had lower 
end~diastolic pressures. Mean systemic and pulmonary ar-
terial pressures were also similar. This is due to higher 
resistance in both systemic and pulmonary circulations in 
dogs not experiencing the initial hyperglycemia. There were 
no consistent changes in arterial blood gases in either 
group of endotoxic dogs. Both groups of endotoxic dogs also 
developed lactacidemia leading to metabolic acidosis to 
about the same degree. 
In glucose clamping experiments all endotoxic dogs 
had similar cardiovascular performance during the clamp. 
However, after terminating the clamp hypoglycemic-clamped 
endotoxic dogs rapidly deteriorated and succumbed to shock 
while hyperglycemic-clamped dogs were protected and normo-
glycemic clamped dogs followed a normal time course. The 
cardiovascular patterns reflect these differences in the 
ability to survive and hypoglycemic-clamped endotoxic dogs 
followed a pattern reminiscent of unclamped dogs which did 
not go through an early hyperglycemic phase. Cardiovascular 
performance was compromised in hypoglycemic-clamped dogs 
given saline to about the same extent as in hyperglycemic-
clamped endotoxic dogs. All endotoxic dogs became acidotic 
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and lactacidemic -- hypoglycemic-clamped endotoxic dogs to 
the greatest extent. Hypoglycemic clamped dogs given saline 
also became acidotic. Both groups of hypoglycemic-clamped 
dogs also tended to become hypoxic and hypercapnic. 
CHAPTER VI 
DISCUSSION 
Metabolic Effects of Endotoxin 
in the Canine-Model 
--
These results, using continuous glucose monitoring, 
conclusively demonstrate two patterns of glucose changes in 
endotoxic dogs: some dogs exhibit an initial hyperglycemic 
phase before becoming hypoglycemic, while other dogs pro-
ceed directly into the hypoglycemic phase. This confirms 
the earlier work of Berk et al. (9) and Hinshaw and col-
leagues (100) using discontinuous sampling of blood glucose. 
The mechanism behind these two patterns is unclear but may 
involve differences in glycogen reserves following an over-
night fast, differences in nutritional status, or differ-
ences in the hormonal milieu. Further study is needed to 
determine the exact mechanism. 
Hyperinsulinemia was also found to occur in the en-
dotoxic dog analogous to the hyperinsulinemia which has al-
ready been demonstrated in the endotoxic rat by Filkins and 
colleagues (23, 220). At no time period did insulin fall 
below control in either group of endotoxic dogs. This re-
sult is in contradiction to several reports in the litera-
ture on endotoxin shock in the dog which either show de-
pressed levels throughout or only early elevations in 
1 21 
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association with a hyperglycemic phase (142, 199). There 
are several explanations for this discrepancy. First, in 
previous studies measurements were made at only a few time 
points. Since considerable fluctuation was seen in the pre-
sent experiments in which measurements were made every 15 
minutes (see Appendix A), it is possible that similar ele-
vations of insulin levels were simply missed in earlier stu-
dies. Differences in the insulin response based on differ-
ences in lethality or endotoxin dose are also possible. 
Finally, the results of the present experiments cannot be 
taken as conclusive evidence of hyperinsulinemia in the dog 
since during glucose clamping experiments the possible pre-
sence of factors in dog serum which lead to spuriously high 
measurements in the radioimmunoassay for insulin was discov-
ered. The nature of this interference is unknown. Since 
dilution of dog reference serum samples gave a reasonable 
standard curve, it is likely that the interfering factor is 
specific for insulin antibodies rather than interfering 
through non-specific binding. This is not an isolated 
nroblem since others have encountered the same nroblem of 
. . 
spuriously high insulin levels in dog serum (personal com-
munication with N. Manson) and is ~orthy of further study 
since it may be the basis for the widely varying results 
obtained in studies of insulin levels in the endotoxic dog 
(14, 142, 199). The question of the role of pancreatic in-
sulin in the develonment of hypoglycemia in the endotoxic 
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dog, thus, remains unanswered. 
During glucose clamping no effect of endotoxin on 
glucose infusion rates was observed. This result is contrary 
to numerous other observations that glucose utilization is 
increased in endotoxic animals (5, 53, 56, 57, 88, 152, 173, 
218). There are several explanations for this discrepancy. 
First, endogenous sources of glucose may be present which 
add to the glucose supplied exogenously by the infusion. 
Thus, the total glucose utilized was not accounted for by 
the infusion. Second, lacking specific information as to 
the glucose space in the endotoxic dog it is impossible to 
correct the glucose infusion rates to the actual glucose 
utilized. Since the glucose space may change following the 
administration of endotoxin and since different infusion 
rates might be due to wider variations of the actual glucose 
level from the desired level rather than differences in uti-
lization, these corrections might be very important in the 
endotoxic dog model. Furthermore, since it became necessary 
to vary the insulin infusion rate as well as the glucose 
infusion rate to lower the glucose level in the normogly-
cemic-clamped dogs and lacking insulin data for the glucose 
clamping experiments, it is difficult to interpret the re-
sults in terms of tissue insulin sensitivity. In addition, 
in some animals it was necessary to give additional bolus 
injections of insulin or glucose in all three of the cla~ps 
in order to maintain the glucose level -- thus, adding 
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another complexity to the analysis and interpretation. 
While normoglycemic·clamped endotoxin dogs had higher insu-
lin infusion rates but similar glucose infusion rates when 
compared to normoglycemic·clamped saline-injected dogs. 
possibly indicating insulin resistance, this conclusion is 
not supported by the results of the other two glucose 
clamps. There was a much greater increase in glucose util-
ization with hyperglycemia in endotoxin dogs thap in saline-
injected dogs (112% versus 43%). Furthermore, while there 
were no statistically significant differences in glucose 
infusion rates in hypoglycemic·clamped dogs, the statistics 
in this case are undoubtedly ~isleading since only one out 
of five dogs in this group given saline required any glucose 
to maintain the clamp level. In contrast, all six endotoxic, 
hypoglycemic-cla~ped dogs required varying amounts of glu-
cose. Both of these results suggest insulin hypersensi-
tivity in the endotoxic dog. Further refinements of the 
glucose clamping technique are clearly needed before these 
techniques can be used in the metabolic analysis of the 
endotoxic dog. In particular, it is necessary to antici-
pate the changes in blood glucose levels to a greater ex-
tent in order to minimize the deviations from the desired 
level as DeFronzo and his colleagues have done (38). While 
the manual control technique used in this study was useful 
in attaining the initial goal of developing a glucose 
clamping model in the endotoxic dog, there are certain 
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drawbacks to this technique. Pacini, Finegood, and Berg-
man (164) have recently pointed out that such human inter-
action entails a degree of bias and is also tedious. Be-
cause of these problems it is desirable to develop auto-
matic means of feedback control of blood glucose for glu-
cose clamping experiments. Thus, better results might be 
obtained if a more mathematical basis for the infusion was 
used rather than the trial-and-error method used in the 
present experiments. If the trial-and-error method, however, 
did not provide satisfactory control of glucose levels, even 
on a crude level, sophisticated mathematical modelling pro-
bably would not have helped. Fairly good control was ob-
tained using the trial-and-error method (see Appendix A); 
this can, however, be improved upon with further refinements 
of the glucose clamping technique. These experiments thus 
provide a good foundation for the development of glucose 
clamping techniques in the endotoxic dog model. 
!h! ~ 2£ Hypoglycemia iu ~ 
Development 2£ Cardiovascular Failure 
iu ~ Endotoxic Dog 
Evidence f~om the ITnclamned Studies 
-------- ---- --- --------~ -------
Associated with the two patterns of glucose changes 
in the unclamped experiments were differences in the pattern 
of circulatory failure. Dogs which did not show the early 
e r~lycemia had poorer cardiac output and stroke work hYP o 
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than dogs which did go through an early hyperglycemic phase. 
The finding of similar left ventricular pressures in the 
group which did not show hyperglycemia but at higher end-
diastolic pressures is also consistent with the poorer 
cardiac function in this group. Since venous return and 
effective blood volume also fall during endotoxin shock 
(J1, 101), endotoxic cardiac failure is complicated by 
changes in preload. This may explain the fall in end-
diastolic pressure in both groups of endotoxic dogs. How-
ever, the lack of any differences in peak systolic pressure 
•• especially in light of a tendency toward greater after-
load as assessed by total peripheral resistance in dogs 
with no hyperglycemic phase -- is harder to explain. Part-
ly this may be the problem of finding statistically sig-
nificant differences between experimental groups using an 
analysis of variance when there are relatively large dif-
ferences between the control group and the experimental 
groups but only small differences between the experimental 
groups. Thus, the variance between the control groups 
and the experimental groups is large but between the exper-
imental groups the variance is small and larger differences 
are needed to find a statistical significance. The high de-
gree of lethality (100%) in both groups of endotoxic dogs 
also would tend to blur any real distinction in the car-
diovascular performance of the two groups. In spite of 
the poorer cardiac performance in dogs not showing early 
hyperglycemia, these dogs were able to maintain similar 
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mean systemic arterial pressures at the tremendous expense 
of progressive increases in peripheral resistance leading 
to further tissue ischemia. Further experiments using a 
less potent model of endotoxin shock are needed to sort out 
the effects of the pattern of glucose dyshomeostasis on car-
diovascular function and the importance of the ability of 
the animal to maintain blood glucose to survival and the 
maintenance of normal circulatory function. 
Evidence from Glucose Clamuing Studies 
Hypoglycemia markedly curtailed survival while hyper-
glycemia even for only the initial two hours after endotoxin 
injection markedly prolonged survival. In contrast, mainte-
nance of normoglycemia over the first two hours of endotox-
icosis left the time course of endotoxin shock unaltered. 
Cardiovascular status paralleled these alterations in sur-
vival. In addition, hypoglycemia tended to depress cardio-
vascular function even without concomitant endotoxemia. 
These effects of glucose clamping could be attri-
buted to mechanisms other than control of blood glucose 
concentrations. First fluids given during the clamp may 
have provided some support to the cardiovascular system 
during shock. Volume overload, on the other hand, may be 
detrimental to an animal already in cardiac failure. The 
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lack of any differences in left ventricular end-diastolic 
pressure between any of the groups except preterminally 
makes it unlikely, however, that this is a factor. Se~ond, 
insulin probably has its own effects on cardiovascular 
runction (82, 117, 125, 161, 208, 211). Both Hiatt and 
coworkers (125, 161) and Downing and associates (82, 208) 
have shown that while insulin has a positive inotropic 
effect of its own, insulin also blocks the positive chron-
otropic and inotropic actions of catecholamines. Thus in-
sulin or an insulin-like activity may in addition to caus-
ing the hypoglycemia of endotoxin shock, block the sup-
portive effects of epinephrine and norepinephrine on the 
the heart. Furthermore, insulin and possibly insulin-like 
agents are known to have a number of effects on ionic 
fluxes -- especially potassium flux (117). Alterations in 
ion fluxes -- especially in the face of hypoglycemia --
may further disturb cardiac electrophysiology. It is 
possible that hyperinsulinism -- whether due to increased 
secretion of insulin by the pancreas or to insulin-like 
activities -- may further impair cardiac performance. 
Since most reports, however, ascribe positive inotropic and 
beneficial effects of insulin infusions under a variety of 
conditions (117, 211), it seems likely that the elevated 
insulin levels -- either because of an insulin infusion or 
in response to a glucose load -- in all three endotoxic 
clamp groups are beneficial and explain the similar levels 
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of cardiovascular variables during the clamp. It seems 
likely that insulin as well as the volume of infusions is 
supporting the cardiovascular system of endotoxic animals 
during these clamps. Following the cessation of all in-
fusions the prevailing glucose level becomes the over-
riding factor in maintaining circulatory function and 
tissue perfusion. It is possible that the hyperinsulinemia 
which occurs following endotoxin administration might be a 
compensatory mechanism which together with hyperglycemia 
provides an endogenous glucose and insulin solution with 
the same beneficial effects as exogenously administered 
glucose-insulin-potassium solutions (117, 211). This mech-
anism -- in a similar manner to increases in peripheral 
resistance which help to maintain blood pressure at the 
expense of tissues which become ischemic -- becomes count-
erproductive and leads to the development of hypoglycemia 
when the hyperglycemia can no longer be maintained. The 
possibility that insulin blocks sympathetic support of the 
myocardium and, therefore, has detrimental effects, as 
postulated by Hiatt (82, 208) and Downing (125, 161) can-
not, however, be eliminated. It seems likely, though, 
that the prevailing glucose levels are the controlling fact-
or. Thus, one can alter the cardiovascular response to the 
administration of endotoxin and the ability of the dog to 
survive simply by altering the glycemic status. Dogs which 
are rendered hyperglycemic receive sufficient glucose to 
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more than keep up with metabolism even after the glucose 
infusion is stopped so that the needs of the cardiovascular 
system during the endotoxic stress continue to be supplied. 
Normoglycemic clamping, on the other hand, provides only 
sufficient glucose to supply the current needs and the hypo-
glycemic clamp removes the preexisting glucose reserve with 
detrimental consequences for cardiovascular functions. 
Hypoglycemia, therefore, plays a detrimental role during the 
course of shock while hyperglycemia appears to be a compen-
satory mechanism to maintain metabolic homeostasis and to 
prevent the ensuing cardiovascular failure. 
Glucose Monitoring~ Glucose Clamping 
~ ~ Treatment 2£ Endotoxin Shock 
These experiments point to the need for metabolic 
as well as circulatory monitoring in septic patients as has 
been proposed by Siegel (192) and Duff (42). The results 
of the glucose clamping studies also indicate that glucose 
clamping may be an effective treatment for shock by helping 
to prevent the circulatory sequelae of sepsis. It is 
unknown whether there is a point where the effects of hypo-
glycemia become irreversible -- in analogy to the Wiggers' 
concept of irreversibility following hemmorhage (214). If 
glucose clamping is to be used as a treatment it is neces-
sary to determine the best treatment regimen -- whether glu-
cose alone or in conjunction with insulin is most effective. 
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clearly it is important to have adequate assessment of 
metabolic status in order to appropriately administer treat-
ment. In these experiments normoglycemic clamping was just 
as effective a treatment as hyperglycemic clamping early 
during the course of shock as assessed by the improvement in 
cardiovascular status, but only the hyperglycemic clamp was 
able to prolong survival following cessation of treatment. 
Furthermore, cardiovascular status deteriorated even in 
hyperglycemic-clamped endotoxic dogs. An assessment must 
be made as to when glucose clamping should be instituted and 
when it is safe to end that treatment. Further studies of 
the rela~ionship of cardiovascular status to glucose homeo-
stasis and the usefulness of glucose clamping as a treatment 
for endotcxic or septic shock are clearly needed. 
Mechanism for the Role of 
Hynoglycemia iu CardiovasCUTar~ailure 
Reticuloendothelial System Involvement 
Buchanan and Filkins (22) demonstrated that hypogly-
cemia depresses phagocytosis of both colloidal carbon and 
endotoxin using an in vivo model of insulin-induced hypogly-
cemia and in vivo tests of phagocytic clearance. Thus, the 
hypoglycemia of endotoxin shock may contribute to the RES 
depression which occurs during endotoxin as well as other 
forms of circulatory shock (39, 59, 188). Since the RES is 
responsible for clearing cardia- and vasotoxic substances 
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as well as endotoxin from the blood, depression of this 
vital function may lead to cardiac and peripheral vascular 
failure following endotoxin administration by allowing·such 
toxic substances to accumulate. In addition, there is ev-
idence that RES depression alone can lead to a state of 
circulatory shock (7, 212, 213). Recently the results of 
Buchanan and Filkins have been confirmed using a slightly 
different model (116). There are, however, some striking 
differences between the quantitative results of this latter 
study and those of Buchanan and Filkins. These differences 
suggest that duration. a.7J.d the rate of induction of hypogly-
cemia may be important factors in the development of RES 
dysfunction as well as the plasma glucose level. Using an 
in situ perfused liver model, Kober and Filkins (116) also 
demonstrated that the hypoglycemic depression of RES phag-
ocytosis is probably due to a direct metabolic effect of 
glucose deprivation on the Kupffer cells of the liver. 
Other mechanisms such as humoral mediators or maldistri-
bution of blood flow in the liver cannot be eliminated 
and may operate in conjunction with a direct effect of 
glucose deprivation. A direct metabolic effect is entirely 
consistent with the evidence for a glucose-based meta-
bolism in macrophages (76, 113, 163, 178, 187). It is 
also of interest to note that the RES may play a role in the 
development of hypoglycemia through its exocytic functions 
(58). Thus, both the endocytic and exocytic functions 
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of the RES may play an extremely important role in the path-
ogenesis of endotoxin shock by providing a positive feedback 
link via hypoglycemia (58). 
The effects of hypoglycemia on RES function in the 
dog have not been explored. However, since this is a po-
tential site for positive feedback in the development of 
circulatory shock, it is in theory an important mechanism. 
Pulmonary Hemodynamics ~ Fluid Balance 
The development of pulmonary edema during hypogly-
cemic episodes has been described clinically (8). The pre-
sence of a fulminating edema was also noted in conjunction 
with the previously mentioned studies of RES depression 
during hypoglycemia (unpublished observations). Two paten-
tial mechanisms for the pathogenesis of this pulmonary 
edema during hypoglycemia have been suggested in the litera-
ture (8). The first is a neurogenic mechanism leading to 
pulmonary vasoconstriction and increased pulmonary vascular 
resistance (139). Such increases in pulmonary vascular 
resistance are also important since the high afterload to 
right ventricular ejection can potentially lead to right 
ventricular failure. The second mechanism is an effect of 
hypoglycemia to increase alveolocapillary permeability --
either directly or indirectly through humoral mediators 
-- leading to increased fluid flux out of the pulmonary 
vasculature (71 ). Thus, through effects on pulmonary 
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vascular resistance and pulmonary capillary fluid balance. 
hypoglycemia can potentially contritute to the myocardial 
failure, hypovolemia, and the systemic hypoxia of endotoxin 
shock. 
Lung fluid balance was not studied in the present set 
of experiments. However, both hypoglycemic-clamped endo-
toxic dogs and unclamped endotoxic dogs without early hyper-
glycemia show increases in pulmonary resistance after the 
administration of endotoxin. The increased pulmonary re-
sistance could have contributed to the poorer cardiovascular 
picture in these groups of dogs by contributing to the de-
velopment of myocardial failure or through an alteration in 
lung fluid balance. The contribution of increased pulmonary 
resistance to cardiovascular failure after endotoxin injec-
tion and the mechanism of the role of hypoglycemia in pro-
ducing increased pulmonary resistance, however, requires 
further study. 
Metabolic Reguirements £! Vascular 
Smooth Muscle 
Until recently it was believed that vascular smooth 
muscle metabolism was largely dependent on carbohydrate as 
a source of fuel. It has now been shown that other sub-
strates can be utilized by vascular smooth muscle (29) and 
that there may be differences between vascular beds (37). 
This issue remains controversial. As for other tissues, 
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glucose becomes a major substrate for vascular smooth 
muscle during hypoxia. It may be that as hypoglycemia and 
hypoxia develop during endotoxin shock that vasoconstriction 
cannot be maintained in non-vital beds. This would lead 
to a fall in systemic arterial pressure and a release of 
cardia- and vasotoxic substances from these beds. Malik 
and McGiff (141), on the other hand, have demonstrated in-
creased responsiveness to adrenergic influences in the 
splanchnic circulation following glucose deprivation. This 
could lead to increased vasoconstriction in the splanchnic 
bed resulting in ischemia and production of cardia- and 
vasotoxic materials from damaged splanchnic organs. Thus, 
potentially, there are two opposing effects of hypoglycemia 
on the peripheral vasculature: decreased substrate avail-
ability to vascular smooth ~uscle and increased responsive-
ness to sympathetic nervous discharge. The balance between 
these two effects will determine the actual response to the 
hypoglycemia of endotoxin shock in a given vascular bed. 
In addition, this balance may change throughout the course 
of shock. 
In these experiments, total peripheral resistance 
was maintained at control or elevated levels up until the 
time of death in all groups of endotoxic dogs. Furthermore, 
peripheral resistance seemed to be a function of cardiac 
output (i.e. the lower the cardiac output the higher the 
peripheral resistance). This implies that the peripheral 
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~asculature is capable of responding to the normal reflexes 
to maintain blood pressure. Thus, an overall effect of glu-
cose deprivation during endotoxin shock on the ability of 
vascular smooth muscle to contract seems not to be present 
in spite of the very low levels of blood glucose. Effects 
on individual beds, however, cannot be ruled out. These 
data, on the other hand, are consistent with an enhancement 
of adrenergic vasoconstrictor mechanisms, since peripheral 
resistance was elevated in unclamped dogs not exhibiting 
early hyperglycemia and in hypoglycemic-clamped endotoxic 
dogs (although this did not reach statistical significance 
because of the high variability in the response of normogly-
cemic-clamped endotoxic dogs). This hypothesis requires 
more direct study of the vascular response to adrenergic 
stimulation after endotoxin and during hypoglycemia. 
Hyuoglycemia ~ Cardiac Function 
during Endotoxicosis 
Evidence from the unclamped experiments suggests 
that the pattern of glucose dyshomeostasis affects primarily 
cardiac function (cardiac output and stroke work are af-
fected by the pattern of glucose dyshomeostasis while the 
~ 
response of the peripheral vasculature follows reflexly to 
support systemic arterial pressure even in late shock. The 
results of the glucose clamping experiments are also con-
sistent with this hypothesis since the same pattern of 
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deteriorating cardiac function with increasing systemic and 
pulmonary resistance is seen in hypoglycemic-clamped endo-
toxic dogs. This is also consistent with the current c_on-
cept that the heart is the major site of circulatory fail-
ure during endotoxicosis rather than the peripheral vascu-
lature (78). However, most of the studies of cardiac func-
tion following endotoxin injection -- including the present 
study -- have measured global circulatory parameters ~uch 
as systemic and pulmonary arterial pressures, cardiac out-
put, and left ventricular pressure which are affected by 
other factors as well as the contractile status of the 
heart. Further investigations utilizing more sophisticated 
means to assess cardiac performance and reserve -- such as 
wall thickness and regional shortening as well as methods 
of probing cardiac function -- are needed to define the role 
of the heart in endotoxic shock in general and more specifi-
cally the effect of the progressive hypoglycemia of endo-
toxin shock on cardiac function. Several mechanisms may 
lead to cardiac failure during endotoxin shock. The role of 
RES, pulmonary resistance, and lung fluid balance have al-
ready been discussed. 
Some of the earliest clue~ to the potential effects 
of hypoglycemia on cardiovascular performance come from 
studies during the era of insulin shock treatments. Ern-
stene and Altschule (47) in 1931 discussed the dangers of 
diminished myocardial reserve during hypoglycemic episodes. 
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In the same year Middleton and Oatway (154) also noted the 
potential for myocardial injury following hypoglycemia. 
Additional evidence for this potential has been provided. 
more recently by Libby, Maroko, and Braunwald (134). How-
ever, their 1975 study provided no information as to the 
mechanism and merely demonstrated the increase in myocar-
dial injury following coronary artery ligation during hypo-
glycemia as assessed by S-T segment changes and myocardial 
creatine phosphokinase levels. Edwards and Page (43) as 
far back as 1924 emphasized the decreased functional capa-
city of the heart during hypoglycemic episodes and made the 
statement that the changes in cardiovascular function which 
they observed during hypoglycemia 11 may present the essential 
features of circulatory failure shock." In addition to 
these observations, the beneficial effects of insulin and 
glucose on the ischemic myocardium and also on the shock 
heart are well-known and have been extensively reviewed 
(117). 
Bricknell and Opie (17, 18) have recently advanced 
the idea, supported by the earlier work of Gercken (66) and 
Gudbjarnason and coworkers (73), that the maintenance of 
membrane function in the heart is dependent on glycolyti-
cally produced ATP, and, thus, on a source of glucose. 
This concept is also supported by the work of Girardier (67) 
and of McDonald, Hunter, and McLeod (148) showing that glu-
cose is necessary for the maintenance of normal action 
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potentials in the heart. As might be expected from this 
concept nodal tissue as well as tissue of the conducting 
system seems to be more dependent on carbohydrate metab~ 
olism (114, 121). These cardiac tissues are also more 
susceptible to the effects of glucose deprivation in the 
race of hypoxia (190). Hypoglycemia -- even without con-
comitant ischemia and hypoxia -- could, thus, lead to al-
tered cardiac electrophysiology, dysrhythmias, depressed 
contractility, and altered responsivity to cholinergic and 
adrenergic influences resulting in autonomic imbalance via 
a depression of myocardial membrane function. Although the 
hypothesis of compartmentalization of ATP is certainly not 
a proven theory, it seems clear that while the major sub-
strate of the heart under most circumstances is free fatty 
acids, the approximately 30% which is glucose and other 
carbohydrates (117) is just as important in maintaining 
normal cardiac function. During myocardial ischemia which 
has been demonstrated during endotoxin shock (15, 94, 115), 
glucose supply becomes even more critical since ATP can only 
be produced from free fatty acids oxidatively (117). Gly-
colysis, on the other hand, requires no oxygen. Further-
more, oxidative metabolism from glucose requires less ox-
ygen than fatty acid metabolism (117). Thus, glucose be-
comes the preferred substrate during ischemia and hypoxia 
when oxygen supply is limited. Numerous studies have shown 
that myocardial function during ischemia and hypoxia is, in 
140 
fact, improved when glucose is supplied as the substrate as 
opposed to free fatty acids (117). In experiments in 
which high levels of free fatty acids were infused in normal 
dogs -- thus, turning off glucose utilization -- ischemic-
like changes were produced in the electrocardiogram (105). 
The importance of glucose to the maintenance of cardiac 
performance is also suggested by clinical evidence that 
there is a relationship between the degree of glucose intol-
erance following myocardial infarction (so-called stress 
diabetes) and the degree of left ventricular dysfunction 
(182, 216). There is some similarity between the metabolic 
problems created by such glucose intolerance and those cre-
ated by the hypoglycemia of endotoxin shock. During stress-
induced glucose intolerance the supply of glucose is intact 
but transport into and utilization by the cells is impaired, 
whereas during endotoxic hypoglycemia the central supply of 
glucose is limited. The net result is effectively the same: 
The myocardial cells do not receive sufficient substrate to 
maintain adequate ventricular performance. It may very well 
be that the supply of glucose is a critical factor in sev-
eral pathophysiological states effecting myocardial per-
formance. Maintenance of normal glucose homeostasis may 
therefore be important in the maintenance of normal cardio-
vascular function. The implication is that the supply man-
agement system and the delivery system are highly integrated 
functions and that neither one works well by itself. This 
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concept is certainly worthy of further study. 
In this set of experiments some support is provided 
for another potential mechanism of the effect of hypoglyce-
mia on the heart. Increases in plasma lactate and decreases 
in pH -- both metabolic and respiratory in origin -- were 
seen in hypoglycemic-clamped dogs even in the saline-in-
j acted grou.p. Furthermore, hypoglycemia exaggerated the 
development of endotoxic lactacidemia and acidosis (metabo-
lic and respiratory). It has been shown that hydrogen ions 
adversely affect cardiac performance (162, 201). However, 
since there was no difference in the pH between the two un-
clamped endotoxic groups the impact of acidosis on cardiac 
function and the contribution of hypoglycemia to that aci-
dosis during endotoxin shock requires further investigation. 
Central Nervous Svstem Depression 
Since glucose is the major substrate of neural tissue 
(46), regulation of cardiovascular and respiratory function 
is deranged during hypoglycemic episodes. The areas of the 
brain which are most sensitive to glucose deprivation are 
the neocortex and the centers involved in cardiovascular 
and respiratory functions (46). Himwich (83) describes a 
progressive failure of the various regions of the brain 
during hypoglycemia, starting from the neocortex and pro-
grassing through the brain stem. These stages are dependent 
on the duration and degree of hypoglycemia. During each 
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stage there are different signs and symptoms which depend 
on the level of consciousness and the prevailing autonomic 
tone. Gellhorn pointed to the autonomic imbalance produced 
by the effects of hypoglycemia on the central nervous system 
__ especially in conjunction with respiratory depression 
leading to hypoxia and hypercapnia (63, 64, 65). Randall 
and coworkers (175, 176, 177, 210) have demonstrated the 
role of autonomic imbalance in the development of cardiac 
dysrhythmias using the technique of intrapericardial dener-
vation. It is also noteworthy that Gellhorn observed pe-
riodic breathing (Cheyne-Stokes respiration) in response 
to hypoxia and hypoglycemia, but not in response to hypo-
glycemia alone (64). Recently Raymond and Emerson (179) 
studied the effects of hypoglycemia and diminished blood 
flow on cerebral metabolism during endotoxin shock in dogs. 
They concluded that the resulting depression of brainstem 
cardiovascular and respiratory centers may be critical to 
the pathogenesis of the shock state. 
In addition to these effects on the central nervous 
system it is also possible that hypoglycemia affects peri-
pheral autonomic nerve function and cardiovascular reflex 
mechanisms. Miles and Hayter (155) discussed the role of 
the baroreceptor reflex in the abnormal response to tilting 
during insulin-induced hypoglycemia sometimes seen in dia-
betics. While diabetic autonomic neuropathies may also be 
a contributory factor in the failure of these patients to 
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maintain blood pressure o~ a tilt table after induction of 
mild hypoglycemia, it is possible that under the more severe 
hypoglycemia of endotoxin shock that the baroreceptor reflex 
will nevertheless be attenuated by this mechanism. Appen-
zeller has suggested that the sensitivity of the barorecep-
tors may be altered by insulin or glucose (2, 3, 24). In 
addition Jarhult and associates have demonstrated effects of 
carotid baroreceptors on the function of pancreatic islets 
as well as their more classical function in the cardiovas-
cular system (111, 112). It is conceivable that insulin 
or glucose may feedback on the baroreceptors. While the 
evidence is largely speculative, hypoglycemia or hyperinsu-
linism might play a role in the resetting ·Of the barorecep-
tors during endotoxic hypotension. 
Summary 
There are, thus, several mechanisms by which hypo-
glycemia can lead to cardiovascular dyshomeostasis and 
shock: 1) reticuloendothelial system depression, 2) altered 
pulmonary vascular fluid balance, 3) increased pulmonary 
vascular resistance, 4) altered vascular smooth muscle 
function, 5) synergism with ischemia to produce myocardial 
dysfunction, 6) acidosis leading to depression of cardiac 
performance, and 7) altered neural regulation of the car-
diovascular and respiratory systems. These hypotheses 
are summarized in figure 19. None of these mechanisms is 
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Fig. 19. Hypothetical scheme of the role of 
hypoglycemia in endotoxin shock 
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mutually exclusive and it is possible -- even probable 
that more than one or even all of them are involved. The 
evidence presented in this study indicates that the major 
effect is most likely depression of myocardial performance 
-- either directly or indirectly rather than the peri-
pheral vasculature. Further experiments are needed to look 
more closely at cardiac performance during endotoxin shock 
and to examine the different hypotheses for the mechanism 
of hypoglycemic depression of the heart. This is an import-
ant area since it opens up additional vistas linking meta-
bolic homeostasis and cardiac function -- an area which 
has largely been ignored. 
CHAPTER VII 
SUMMARY AND CONCLUSIONS 
A canine model for the continuous monitoring of 
blood glucose levels during endotoxic shock has been de-
veloped. This model has been used to develop the technique 
of glucose clamping at hypo-, norma-, and hyperglycemic 
levels in order to study glucose metabolism during endo-
toxin shock and the relationship of derangements in glucose 
homeostasis to the development of the collapse of the cir-
culatory system. 
Because of the use of continuous glucose monitoring, 
it has been conclusively demonstrated that some dogs go 
through an early hyperglycemic phase while others do not. 
Previously, with the availability of only discontinuous 
sampling, it was possible that the early hyperglycemic 
phase was simply missed by the sampling rather than being 
non-existent. The mechanism regulating whether a hypergly-
cemic phase will occur is not known. Regardless of whether 
an animal showed early hyperglycemia or not following the 
administration of endotoxin, a hyperinsulinemia with a 
highly variable time course was seen to occur during endo-
toxin shock. However, since in some cases spuriously high 
insulin levels could be obtained because of the presence 
of an interfering factor, the existence of hyperinsulinemia 
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in the endotoxic dog has not been conclusively demonstrated. 
These results also have demonstrated that metabolic 
failure leading to profound hypoglycemia following endo-
toxin injection is an important -- even critical -- factor 
in the development of cardiovascular collapse while the in-
itial hyperglycemia is a part of the compensatory mechanism 
to prevent the circulatory failure and its lethal conse-
quences. The results are consistent with an effect of hypo-
glycemia to depress cardiac function in the endotoxic dog. 
Further experiments are needed to determine the exact mech-
anism of the effects of hypoglycemia on cardiac performance. 
The peripheral vasculature remains under neural control to 
maintain blood pressure but this is accomplished at the tre-
mendous cost of reflex vasoconstriction leading to tissue 
ischemia. The results also suggest that glucose dyshomeo-
stasis may also contribute to the increase in pulmonary re-
sistance seen during endotoxin shock. Such increases in 
pulmonary resistance may contribute to the development of 
cardiac failure. Glucose clamping may be an effective 
treatment for the circulatory sequelae of endotoxin shock. 
Further refinements of the glucose clamping technique are 
needed before the technique can be used in a treatment re-
gimen to prevent the hypoglycemia and the resulting cir-
culatory failure following endotoxin administration. 
Thus, in conclusion: 
1) The ability to maintain and even elevate 
blood glucose levels is intimately asso-
ciated with the ability to maintain car-
diovascular function after endotoxin in-
jection. 
2) Conversely, the development of metabolic 
failure leading to profound, progressive 
hypoglycemia is critically involved in 
the circulatory collapse seen following 
endotoxin administration. 
3) Hypoglycemia adversely affects cardiac 
performance during endotoxicosis. 
4) Periphera·l vascular mechanisms are still 
able to maintain blood pressure but at the 
cost of tremendous increases in resistance 
leading to tissue ischemia. 
5) Glucose clamping to maintain a hypergly-
cemic state may be an effective treat-
ment regimen to prevent the circulatory 
sequelae of endotoxin shock. 
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6) Further experimentation is needed to in-
vestigate the effect of the glucose dys-
homeostasis of endotoxin shock on cardiac 
performance. 
7) Further experimentation is also needed 
to refine the glucose clamping tech-
nique for further studies of endotoxic 
glucose metabolism in the dog and for 
the development of an effective treat-
ment to prevent the progression to 
circulatory failure and shock. 
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APPENDIX A 
APPENDIX A 
Additional Data Presentation 
The following five figures show presentations of data 
for selected parameters for individual dogs in the unclamped 
groups (figures 20-23) and the average glucose levels during 
the clamps in the glucose clamping groups (figure 24). The 
4 figures from the unclamped experiments demonstrate the 
wide variability in the time course of endotoxin shock in 
these sets of experiments and also show the two patterns of 
blood glucose changes seen (figue 20). Also seen in these 
figures is the highly variable pattern of serum insulin (fig-
ure 21). Figure 24 shows the average glucose levels during 
the glucose. clamps. Statistical analysis (a factorial ana-
lysis of variance) demonstrates that all three clamps were 
different (P<0.05) with no differences between corresponding 
endotoxin and saline groups (P>0.1), 
174 
175 
Fig. 20. Glucose: Individual Dogs -- Unclamped 
Experiments. Bottom=Endotoxin w/no 
hyperglycemia, Middle=Endotoxin 
w/hyperglycemia. Top=saline. 
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Fig. 21. Insulin: Individual Dogs -- Unclamped 
Experiments. Bottom=Endotoxin w/no 
hyperglycemia, Middle=Endotoxin 
w/hyperglycemia, Top=saline. 
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Fig. 22. Cardiac Output: Individual Dogs --
Unclamped Experiments. Bottom= 
Endotoxin w/no hyperglycemia, 
Middle=Endotoxin w/hyperglycemia, 
Top=saline. 
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Fig. 23. Mean Systemic Arterial Pressure: 
Individual Dogs -- Unclamped 
Experiments. Bottom=Endotoxin 
w/no hyperglycemia, Middle= 
Endotoxin w/hyperglycemia, 
Top=saline. 
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Fig. 24. Glucose Clamns: ~Endotoxin, 
Hypoglycemic-Clamp (N=6); 
#Saline, Hypoglycemic Clamp (N=5); 
X Endotoxin, Normoglycemic Clamp (N=4); 
0 Saline, Normoglycemic Clamp (N=J); 
*Endotoxin, Hyperglycemic Clamp (N=4); 
~Saline, Hyperglycemic Clamp (N=J). 
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APPENDIX B 
APPENDIX B 
RIA PROGRAM 
The following program, written in PFOCAL on PDP12 
computer, was used to analyze the insulin data. Data from 
the gamma counter is read by the computer via paper tape. 
The program consists of two parts: 1) the main program 
and 2) the log-legit linear regression subroutine which is 
accessed by the main program. 
~ E1! Program 
01. 01 C RIA 
01. 20 C CALCULATES RIA FROM DATA ENTERED INTO THE COMPUTER 
01. 30 C VIA PAPER TAPE FROM GAMMA COUNTER 
01. 40 C DEVELOPED BY P.M. KOBER AND M. R. YELICH 
01. 50 C AUGUST 13, 1980 
01. 60 A !!!"EXPERIMENT IDENTIFICATION #:"D 
01. 70 A !!"NUMBER OF ASSAY TUBES?"N1 
01. 80 D 8 
01 • 90 D 9 
02. 05 S K=O 
02. 10 T "itlELL # 
(K-1 ) 2. 
02. 15 T :53"IRI 
o2. 20 T ! ; D 6 
02. 30 T ! ! ! ! ! ; S 
CPM(CH A) B/BO 
2,2. 15 
AVG IRI" 
K=1 ; D 2. 1 ; T 
04. 10 C IRI CALCULATIONS ?OR SAHPLES 
04. 20 0 R I 
04. 27 S K=);S S1=0;S I1=0 
04. 30 F J=20,N1;D 5 
04. 40 Q 
05. 10 C SAMPLES 
05. 20 A N, M, S, M, M, M 
05. 30 S S2=S-BL;S S2=S2/H;S P(K)=S2 
186 
%B AVG %B"I 
05. 40 I (K-1)5. 5,5. 9 
05. 50 S S1=S1+S2;S K=i 
187 
05. 60S I=FEXP(((FLOG(S2/(1-S2))-B)/Q)*FLOG(10));S I1=I1+I 
05. 70 0 I TTY 
05. 75 T !,%4. OO,N, :9,%7 •. 01,5, :23,%4. 03,32, :31,%4. 01,. 
100*52, :51%3. OO,I 
05. 80 0 R I; R 
05. 90 S S1=(S1+S2)/2;S K=O 
05. 92 S I=FEXP(((FLOG(S2/(1-S2))-B)/Q*FLOG(10));S I1=(I1+I) 
/2 
05. 94 0 I TTY: 
05. 97 T , :51,%3. 00, I, :59, I1; I (FABS(P(O)-P(1) )-. 05)5. 
98,5. 98;T :62"*" 
05. 98 S I1=0;S 51=0 
05. 99 0 R I;R 
06. 10 C STANDARD CURVE CALCULATION 
06. 20 0 I DF:RIA.FD 
06. 30 F J=1,3;A M, M, M, M, M, M 
06. 40 S K=O;S D1=0 
06. 50 F J=4,19;D 7 
06. 60 0 I TTY:,ECHO 
06 70 L G STCURV 
07. 05 C STANDARDS 
0 7 • 1 0 A N , M , S , M , t·! , ~1 
07. 20 S S=S-BL;S S(J)=S/H 
07. 30 I (K-1)7. 4,7.8 
07. 40 S S1=S1+S(J);S K=1 
07. 50 0 I TTY: 
07. 60 T !,%4. OO,N, :9,%7. 01,S+BL, :23,%4. 03,S(J), :31,%4. 
01,100*S(J) 
07. 70 0 R I;R 
07. 80 S S1=(S1+S(J))/2;S K=O 
07. 90 0 I TTY: 
07. 92 T !,%4. OO,N, :9,%7. 01,S+BL, :23,%4. 03,S(J), :31, 
%4. 01,100*S(J), :40,31*100 
07. 94 S S1=0 
07. 96 0 R I;R 
08. 10 C BLANK CALCULATION 
08. 20 0 I DF :RIA. FD 
08. 30 F J=1,3;A M, M, X(J),M, M, M 
08. 40 0 I TTY: 
08. 50S BL=(X(2)+X(3))/2 
08. 60 T !!!"CPM FOR BLANK+ "%6. 02,BL 
09. 10 C STANDARD H CALCULATION (EO) 
09. 20 S H=O 
09. 30 0 R I 
09. 40 F J=4,19;D 10 
09. 50 0 c 
09. 60 S H=H/2-BL 
09. 70 T !"CPM FOR SAMPLE H (BO)="H, !!!!! 
10. 05 C STANDARD H 
10. 10 A M,M,H1,M,M,M;I (J-18)10. 2;S H=H+H1 
10. 20 R 
188 
01. 10 C STCURV 
Log-Legit Linear Regression 
Subroutine 
189 
01. 20 C LOG-LOGIT REGRESSION OF STANDARD CURVE FOR INSULIN 
RIA 
01. 30 C USED AS SUBROUTINE FOR RIA PROGRAM 
01. 40 C DEVELOPED BY P. KOBER AND M. R. YELICH 
01. 50 C AUGUST 13, 1980 
01. 60S SX=O;S X2=0;S SY=);S Y2=0;S N2=14 
01. 65 S D=193 
01 • 67 T ! ! ! ! ! 
01. 70 F J=4,2,16;T !"STD DOSE ";S D=FOUT(D);A "?"S1;S S1(J) 
=S1;S S1(J+1)=S1;S D 
01. 80 F J=4,17;D 3 
02. 10 S DX=X2-SXA2/N2;S DY=Y2-SYA2/N2 
02. 20 S Q=(XY-SX*SY/N2)/DX;S B=(SY-SX*Q)/N2 
02. 30 S R=Q*DX/FSQT(DX*DY);S S=DY-QA2*DX;S E=FSQT(S/(N2-2)) 
02. 40 T !!!!!%4. 03"LOGIT Y=",Q, "*LOG X+"%5. 03,B, "+/-"E 
02. 50 T !rrR="R 
02. 56 T !! 
02. 60 A "GOOD STANDARD CURVE?D;T !!!!! 
02. 70 I (D-OYES)4. 1 ;R 
03. 10 S X=FLOG(S1(J))/FLOG(10);S Y=FLOG(S(J)/(1-S(J))) 
03. 20 S SX=SX+X;S X2=X2+XA2;S SY=SY+Y;S Y2=Y2+YA2; XY=XY+ 
X*Y 
04. 10 A "HOW MANY BAD POINTS?"D 
04. 20 F G=1,D;D 5 
04. 25 S N2=N2-D 
04. 30 G 2. 1 
05. 10 T "DOSE AND NUMBER OF BAD POINT"%3.00,G;A "?"S1,V 
05. 20 S X=FLOG(S1)/FLOG(10);S Y=FLOG(S(V)/(!-S(V))) 
05. 30 S SX=SX-X;S X2=X2-XA2;S SY=SY-Y;S Y2=Y2-A2;S 
XY=XY-X*Y 
* 
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